| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.861 | 0.005 | 0.861 | Caspase 9 stimulant | 0.861 0.005 DB00154 0.832 0.007 DBMET02087 0.592 0.037 DBMET02086 0.861 0.005 DB04557 0.775 0.015 DB00917 | ||
| 0.859 | 0.004 | 0.936 | Platelet antagonist | 0.859 0.004 DB00154 0.882 0.004 DBMET02087 0.914 0.003 DBMET02086 0.859 0.004 DB04557 0.936 0.003 DB00917 | DB00917 | |
| 0.815 | 0.004 | 0.815 | Cholesterol antagonist | 0.815 0.004 DB00154 0.788 0.004 DBMET02087 0.665 0.011 DBMET02086 0.815 0.004 DB04557 0.618 0.016 DB00917 | ||
| 0.817 | 0.013 | 0.881 | Antiinflammatory | 0.817 0.013 DB00154 0.881 0.006 DBMET02087 0.619 0.048 DBMET02086 0.817 0.013 DB04557 0.686 0.034 DB00917 | DBMET02087 | |
| 0.772 | 0.004 | 0.987 | Vasodilator, peripheral | 0.772 0.004 DB00154 0.879 0.003 DBMET02087 0.976 0.001 DBMET02086 0.772 0.004 DB04557 0.987 0.001 DB00917 | DB00917 | |
| 0.736 | 0.004 | 0.736 | Angiogenesis stimulant | 0.736 0.004 DB00154 0.576 0.008 DBMET02087 0.284 0.055 DBMET02086 0.736 0.004 DB04557 0.356 0.031 DB00917 | ||
| 0.733 | 0.011 | 0.733 | Cyclophilin D inhibitor | 0.733 0.011 DB00154 0.705 0.014 DBMET02087 0.426 0.077 DBMET02086 0.733 0.011 DB04557 0.39 0.096 DB00917 | ||
| 0.716 | 0.007 | 0.952 | Antithrombotic | 0.716 0.007 DB00154 0.83 0.004 DBMET02087 0.937 0.002 DBMET02086 0.716 0.007 DB04557 0.952 0.001 DB00917 | DB00917 | |
| 0.683 | 0.005 | 0.795 | Hypolipemic | 0.683 0.005 DB00154 0.795 0.004 DBMET02087 0.65 0.005 DBMET02086 0.683 0.005 DB04557 0.63 0.005 DB00917 | DBMET02087 | |
| 0.675 | 0.005 | 0.717 | Apoptosis antagonist | 0.675 0.005 DB00154 0.717 0.004 DBMET02087 0.407 0.036 DBMET02086 0.675 0.005 DB04557 0.397 0.039 DB00917 | DBMET02087 | |
| 0.659 | 0.002 | 0.659 | GABA C receptor agonist | 0.659 0.002 DB00154 0.368 0.006 DBMET02087 0.153 0.033 DBMET02086 0.659 0.002 DB04557 0.117 0.052 DB00917 | ||
| 0.648 | 0.005 | 0.842 | Platelet aggregation inhibitor | 0.648 0.005 DB00154 0.665 0.005 DBMET02087 0.776 0.004 DBMET02086 0.648 0.005 DB04557 0.842 0.004 DB00917 | DB00917 | |
| 0.63 | 0.002 | 0.63 | Succinate dehydrogenase inhibitor | 0.63 0.002 DB00154 0.488 0.003 DBMET02087 0.248 0.023 DBMET02086 0.63 0.002 DB04557 0.216 0.037 DB00917 | ||
| 0.614 | 0.004 | 0.614 | Phospholipase C inhibitor | 0.614 0.004 DB00154 0.61 0.004 DBMET02087 0.328 0.016 DBMET02086 0.614 0.004 DB04557 0.335 0.015 DB00917 | ||
| 0.603 | 0.006 | 0.758 | Vasodilator | 0.603 0.006 DB00154 0.69 0.004 DBMET02087 0.737 0.004 DBMET02086 0.603 0.006 DB04557 0.758 0.004 DB00917 | DB00917 | |
| 0.63 | 0.043 | 0.664 | Apoptosis agonist | 0.63 0.043 DB00154 0.664 0.037 DBMET02087 0.455 0.089 DBMET02086 0.63 0.043 DB04557 0.55 0.06 DB00917 | DBMET02087 | |
| 0.588 | 0.004 | 0.588 | Aldehyde dehydrogenase inhibitor | 0.588 0.004 DB00154 0.581 0.004 DBMET02087 0.118 0.073 DBMET02086 0.588 0.004 DB04557 0.149 0.048 DB00917 | ||
| 0.575 | 0.003 | 0.58 | Vanilloid agonist | 0.575 0.003 DB00154 0.58 0.003 DBMET02087 0.108 0.026 DBMET02086 0.575 0.003 DB04557 0.142 0.012 DB00917 | DBMET02087 | |
| 0.581 | 0.012 | 0.581 | Histamine release inhibitor | 0.581 0.012 DB00154 0.538 0.019 DBMET02087 0.394 0.079 DBMET02086 0.581 0.012 DB04557 | ||
| 0.56 | 0.004 | 0.593 | Platelet adhesion inhibitor | 0.56 0.004 DB00154 0.593 0.004 DBMET02087 0.529 0.005 DBMET02086 0.56 0.004 DB04557 0.579 0.004 DB00917 | DBMET02087 | |
| 0.564 | 0.01 | 0.564 | Hypoglycemic | 0.564 0.01 DB00154 0.487 0.016 DBMET02087 0.272 0.064 DBMET02086 0.564 0.01 DB04557 0.261 0.071 DB00917 | ||
| 0.556 | 0.016 | 0.603 | Immunomodulator | 0.556 0.016 DB00154 0.603 0.011 DBMET02087 0.563 0.015 DBMET02086 0.556 0.016 DB04557 0.524 0.02 DB00917 | DBMET02087 | |
| 0.556 | 0.019 | 0.712 | Immunosuppressant | 0.556 0.019 DB00154 0.575 0.016 DBMET02087 0.701 0.005 DBMET02086 0.556 0.019 DB04557 0.712 0.005 DB00917 | DB00917 | |
| 0.539 | 0.005 | 0.539 | Alpha-N-acetylglucosaminidase inhibitor | 0.539 0.005 DB00154 0.459 0.006 DBMET02087 0.177 0.042 DBMET02086 0.539 0.005 DB04557 0.137 0.063 DB00917 | ||
| 0.565 | 0.036 | 0.614 | Transcription factor NF kappa B inhibitor | 0.565 0.036 DB00154 0.581 0.034 DBMET02087 0.522 0.041 DBMET02086 0.565 0.036 DB04557 0.614 0.029 DB00917 | DB00917 | |
| 0.547 | 0.026 | 0.547 | Aldehyde oxidase inhibitor | 0.547 0.026 DB00154 0.374 0.051 DBMET02087 0.547 0.026 DB04557 | ||
| 0.52 | 0.006 | 0.532 | Interleukin 2 agonist | 0.52 0.006 DB00154 0.5 0.008 DBMET02087 0.532 0.005 DBMET02086 0.52 0.006 DB04557 0.527 0.005 DB00917 | DBMET02086 | |
| 0.522 | 0.016 | 0.564 | Lipoxygenase inhibitor | 0.522 0.016 DB00154 0.564 0.012 DBMET02087 0.262 0.092 DBMET02086 0.522 0.016 DB04557 0.337 0.055 DB00917 | DBMET02087 | |
| 0.507 | 0.004 | 0.507 | 5 Hydroxytryptamine uptake stimulant | 0.507 0.004 DB00154 0.34 0.029 DBMET02087 0.225 0.11 DBMET02086 0.507 0.004 DB04557 0.191 0.172 DB00917 | ||
| 0.523 | 0.02 | 0.523 | GABA C receptor rho-3 antagonist | 0.523 0.02 DB00154 0.277 0.132 DBMET02087 0.523 0.02 DB04557 | ||
| 0.507 | 0.004 | 0.507 | Protein kinase stimulant | 0.507 0.004 DB00154 0.507 0.004 DBMET02087 0.418 0.007 DBMET02086 0.507 0.004 DB04557 0.415 0.007 DB00917 | ||
| 0.508 | 0.019 | 0.508 | Caspase 3 stimulant | 0.508 0.019 DB00154 0.443 0.031 DBMET02087 0.307 0.075 DBMET02086 0.508 0.019 DB04557 0.457 0.028 DB00917 | ||
| 0.492 | 0.004 | 0.523 | Phospholipase A2 inhibitor | 0.492 0.004 DB00154 0.523 0.004 DBMET02087 0.211 0.037 DBMET02086 0.492 0.004 DB04557 0.195 0.045 DB00917 | DBMET02087 | |
| 0.489 | 0.007 | 0.667 | Non-steroidal antiinflammatory agent | 0.489 0.007 DB00154 0.667 0.004 DBMET02087 0.234 0.05 DBMET02086 0.489 0.007 DB04557 0.308 0.026 DB00917 | DBMET02087 | |
| 0.501 | 0.029 | 0.568 | Immunostimulant | 0.501 0.029 DB00154 0.568 0.021 DBMET02087 0.537 0.024 DBMET02086 0.501 0.029 DB04557 0.552 0.022 DB00917 | DBMET02087 | |
| 0.481 | 0.01 | 0.491 | Interleukin agonist | 0.481 0.01 DB00154 0.436 0.014 DBMET02087 0.491 0.009 DBMET02086 0.481 0.01 DB04557 0.429 0.015 DB00917 | DBMET02086 | |
| 0.474 | 0.004 | 0.474 | Tyrosine 3 hydroxylase inhibitor | 0.474 0.004 DB00154 0.295 0.036 DBMET02087 0.198 0.14 DBMET02086 0.474 0.004 DB04557 | ||
| 0.472 | 0.004 | 0.748 | Gastrin inhibitor | 0.472 0.004 DB00154 0.409 0.004 DBMET02087 0.677 0.002 DBMET02086 0.472 0.004 DB04557 0.748 0.001 DB00917 | DB00917 | |
| 0.495 | 0.028 | 0.495 | 5 Hydroxytryptamine release stimulant | 0.495 0.028 DB00154 0.351 0.056 DBMET02087 0.375 0.051 DBMET02086 0.495 0.028 DB04557 0.186 0.134 DB00917 | ||
| 0.467 | 0.004 | 0.467 | Insulin sensitizer | 0.467 0.004 DB00154 0.444 0.005 DBMET02087 0.233 0.045 DBMET02086 0.467 0.004 DB04557 0.222 0.053 DB00917 | ||
| 0.492 | 0.035 | 0.492 | 5 Hydroxytryptamine release inhibitor | 0.492 0.035 DB00154 0.374 0.096 DBMET02087 0.286 0.181 DBMET02086 0.492 0.035 DB04557 | ||
| 0.482 | 0.026 | 0.846 | Spasmolytic | 0.482 0.026 DB00154 0.518 0.021 DBMET02087 0.766 0.005 DBMET02086 0.482 0.026 DB04557 0.846 0.004 DB00917 | DB00917 | |
| 0.455 | 0.003 | 0.455 | Ferrochelatase inhibitor | 0.455 0.003 DB00154 0.277 0.01 DBMET02087 0.455 0.003 DB04557 | ||
| 0.475 | 0.023 | 0.521 | Antioxidant | 0.475 0.023 DB00154 0.521 0.018 DBMET02087 0.374 0.04 DBMET02086 0.475 0.023 DB04557 0.395 0.036 DB00917 | DBMET02087 | |
| 0.45 | 0.002 | 0.45 | Adenylate kinase inhibitor | 0.45 0.002 DB00154 0.415 0.003 DBMET02087 0.189 0.017 DBMET02086 0.45 0.002 DB04557 0.231 0.011 DB00917 | ||
| 0.456 | 0.011 | 0.456 | Anesthetic general | 0.456 0.011 DB00154 0.257 0.047 DBMET02087 0.207 0.071 DBMET02086 0.456 0.011 DB04557 | ||
| 0.444 | 0.004 | 0.444 | TRPA1 agonist | 0.444 0.004 DB00154 0.396 0.004 DBMET02087 0.129 0.049 DBMET02086 0.444 0.004 DB04557 0.16 0.025 DB00917 | ||
| 0.442 | 0.004 | 0.81 | Prostaglandin EP2 antagonist | 0.442 0.004 DB00154 0.503 0.003 DBMET02087 0.802 0.001 DBMET02086 0.442 0.004 DB04557 0.81 0.001 DB00917 | DB00917 | |
| 0.44 | 0.004 | 0.44 | Porphobilinogen synthase inhibitor | 0.44 0.004 DB00154 0.141 0.022 DBMET02087 0.44 0.004 DB04557 | ||
| 0.429 | 0.004 | 0.89 | Prostaglandin antagonist | 0.429 0.004 DB00154 0.33 0.005 DBMET02087 0.757 0.003 DBMET02086 0.429 0.004 DB04557 0.89 0.002 DB00917 | DB00917 | |
| 0.426 | 0.011 | 0.426 | Sodium/bile acid cotransporter inhibitor | 0.426 0.011 DB00154 0.389 0.02 DBMET02087 0.368 0.029 DBMET02086 0.426 0.011 DB04557 0.358 0.035 DB00917 | ||
| 0.419 | 0.005 | 0.419 | Cell adhesion inhibitor | 0.419 0.005 DB00154 0.385 0.005 DBMET02087 0.419 0.005 DB04557 | ||
| 0.41 | 0.003 | 0.41 | Vanilloid 1 agonist | 0.41 0.003 DB00154 0.39 0.003 DBMET02087 0.171 0.023 DBMET02086 0.41 0.003 DB04557 0.174 0.021 DB00917 | ||
| 0.42 | 0.023 | 0.42 | Superoxide dismutase inhibitor | 0.42 0.023 DB00154 0.211 0.106 DBMET02087 0.42 0.023 DB04557 | ||
| 0.439 | 0.047 | 0.468 | Toll-Like receptor agonist | 0.439 0.047 DB00154 0.468 0.039 DBMET02087 0.281 0.123 DBMET02086 0.439 0.047 DB04557 0.304 0.108 DB00917 | DBMET02087 | |
| 0.404 | 0.015 | 0.404 | Growth hormone agonist | 0.404 0.015 DB00154 0.313 0.03 DBMET02087 0.322 0.028 DBMET02086 0.404 0.015 DB04557 0.234 0.048 DB00917 | ||
| 0.443 | 0.059 | 0.521 | Antibacterial | 0.443 0.059 DB00154 0.521 0.035 DBMET02087 0.454 0.055 DBMET02086 0.443 0.059 DB04557 0.464 0.052 DB00917 | DBMET02087 | |
| 0.439 | 0.058 | 0.439 | 15-Lipoxygenase inhibitor | 0.439 0.058 DB00154 0.439 0.058 DB04557 | ||
| 0.381 | 0.002 | 0.381 | Prolactin inhibitor | 0.381 0.002 DB00154 0.31 0.003 DBMET02087 0.103 0.052 DBMET02086 0.381 0.002 DB04557 0.112 0.044 DB00917 | ||
| 0.405 | 0.03 | 0.408 | Interleukin antagonist | 0.405 0.03 DB00154 0.408 0.03 DBMET02087 0.209 0.079 DBMET02086 0.405 0.03 DB04557 0.232 0.069 DB00917 | DBMET02087 | |
| 0.379 | 0.006 | 0.394 | 5-Lipoxygenase inhibitor | 0.379 0.006 DB00154 0.394 0.005 DBMET02087 0.379 0.006 DB04557 | DBMET02087 | |
| 0.375 | 0.003 | 0.375 | Toll-Like receptor 2 antagonist | 0.375 0.003 DB00154 0.344 0.004 DBMET02087 0.193 0.027 DBMET02086 0.375 0.003 DB04557 0.208 0.02 DB00917 | ||
| 0.382 | 0.01 | 0.382 | Lipid peroxidase inhibitor | 0.382 0.01 DB00154 0.307 0.018 DBMET02087 0.382 0.01 DB04557 | ||
| 0.375 | 0.004 | 0.375 | Catalase inhibitor | 0.375 0.004 DB00154 0.28 0.007 DBMET02087 0.074 0.052 DBMET02086 0.375 0.004 DB04557 | ||
| 0.392 | 0.022 | 0.392 | Peroxidase inhibitor | 0.392 0.022 DB00154 0.263 0.045 DBMET02087 0.392 0.022 DB04557 | ||
| 0.373 | 0.004 | 0.373 | Glutamate dehydrogenase inhibitor | 0.373 0.004 DB00154 0.278 0.006 DBMET02087 0.113 0.025 DBMET02086 0.373 0.004 DB04557 0.09 0.036 DB00917 | ||
| 0.369 | 0.003 | 0.68 | Prostaglandin F2 alpha antagonist | 0.369 0.003 DB00154 0.466 0.002 DBMET02087 0.602 0.001 DBMET02086 0.369 0.003 DB04557 0.68 0.001 DB00917 | DB00917 | |
| 0.385 | 0.024 | 0.385 | DNA synthesis inhibitor | 0.385 0.024 DB00154 0.345 0.031 DBMET02087 0.264 0.058 DBMET02086 0.385 0.024 DB04557 0.242 0.072 DB00917 | ||
| 0.375 | 0.016 | 0.525 | Hepatoprotectant | 0.375 0.016 DB00154 0.355 0.018 DBMET02087 0.479 0.008 DBMET02086 0.375 0.016 DB04557 0.525 0.006 DB00917 | DB00917 | |
| 0.368 | 0.013 | 0.368 | Monophenol monooxygenase inhibitor | 0.368 0.013 DB00154 0.278 0.02 DBMET02087 0.146 0.048 DBMET02086 0.368 0.013 DB04557 0.14 0.051 DB00917 | ||
| 0.359 | 0.005 | 0.359 | Mediator release inhibitor | 0.359 0.005 DB00154 0.331 0.006 DBMET02087 0.359 0.005 DB04557 | ||
| 0.354 | 0.004 | 0.354 | Phosphofructokinase-1 inhibitor | 0.354 0.004 DB00154 0.316 0.005 DBMET02087 0.199 0.011 DBMET02086 0.354 0.004 DB04557 0.164 0.016 DB00917 | ||
| 0.352 | 0.004 | 0.352 | Alcohol oxidase inhibitor | 0.352 0.004 DB00154 0.187 0.007 DBMET02087 0.055 0.04 DBMET02086 0.352 0.004 DB04557 | ||
| 0.354 | 0.008 | 0.354 | DNA polymerase I inhibitor | 0.354 0.008 DB00154 0.274 0.014 DBMET02087 0.257 0.016 DBMET02086 0.354 0.008 DB04557 0.259 0.015 DB00917 | ||
| 0.349 | 0.004 | 0.349 | Triose-phosphate isomerase inhibitor | 0.349 0.004 DB00154 0.279 0.005 DBMET02087 0.146 0.021 DBMET02086 0.349 0.004 DB04557 0.1 0.047 DB00917 | ||
| 0.346 | 0.002 | 0.346 | Aconitate hydratase inhibitor | 0.346 0.002 DB00154 0.253 0.003 DBMET02087 0.076 0.016 DBMET02086 0.346 0.002 DB04557 0.061 0.025 DB00917 | ||
| 0.373 | 0.032 | 0.412 | Tumour necrosis factor alpha release inhibitor | 0.373 0.032 DB00154 0.412 0.025 DBMET02087 0.203 0.107 DBMET02086 0.373 0.032 DB04557 0.228 0.087 DB00917 | DBMET02087 | |
| 0.343 | 0.004 | 0.343 | Peroxisome proliferator-activated receptor gamma agonist | 0.343 0.004 DB00154 0.319 0.004 DBMET02087 0.101 0.027 DBMET02086 0.343 0.004 DB04557 0.118 0.021 DB00917 | ||
| 0.361 | 0.023 | 0.361 | RNA-directed DNA polymerase inhibitor | 0.361 0.023 DB00154 0.259 0.045 DBMET02087 0.361 0.023 DB04557 | ||
| 0.401 | 0.065 | 0.401 | Antiobesity | 0.401 0.065 DB00154 0.305 0.113 DBMET02087 0.401 0.065 DB04557 | ||
| 0.334 | 0.003 | 0.334 | Glycine transporter 2 inhibitor | 0.334 0.003 DB00154 0.1 0.013 DBMET02087 0.334 0.003 DB04557 | ||
| 0.343 | 0.013 | 0.343 | Protein-tyrosine phosphatase inhibitor | 0.343 0.013 DB00154 0.293 0.02 DBMET02087 0.343 0.013 DB04557 | ||
| 0.344 | 0.017 | 0.405 | Melanin inhibitor | 0.344 0.017 DB00154 0.349 0.016 DBMET02087 0.343 0.017 DBMET02086 0.344 0.017 DB04557 0.405 0.011 DB00917 | DB00917 | |
| 0.327 | 0.007 | 0.327 | Interleukin 4 antagonist | 0.327 0.007 DB00154 0.312 0.008 DBMET02087 0.232 0.016 DBMET02086 0.327 0.007 DB04557 0.222 0.017 DB00917 | ||
| 0.321 | 0.004 | 0.321 | Transcription factor NF kappa B stimulant | 0.321 0.004 DB00154 0.248 0.006 DBMET02087 0.088 0.054 DBMET02086 0.321 0.004 DB04557 0.113 0.029 DB00917 | ||
| 0.319 | 0.002 | 0.319 | Lysophosphatidic acid 2 receptor antagonist | 0.319 0.002 DB00154 0.162 0.003 DBMET02087 0.319 0.002 DB04557 | ||
| 0.326 | 0.01 | 0.505 | Insulin secretagoues | 0.326 0.01 DB00154 0.505 0.005 DBMET02087 0.176 0.051 DBMET02086 0.326 0.01 DB04557 | DBMET02087 | |
| 0.321 | 0.005 | 0.321 | Catenin beta inhibitor | 0.321 0.005 DB00154 0.235 0.015 DBMET02087 0.321 0.005 DB04557 | ||
| 0.32 | 0.005 | 0.32 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.32 0.005 DB00154 0.225 0.012 DBMET02087 0.16 0.024 DBMET02086 0.32 0.005 DB04557 0.096 0.058 DB00917 | ||
| 0.317 | 0.003 | 0.317 | Glutamate decarboxylase inhibitor | 0.317 0.003 DB00154 0.232 0.005 DBMET02087 0.082 0.043 DBMET02086 0.317 0.003 DB04557 0.064 0.063 DB00917 | ||
| 0.381 | 0.068 | 0.407 | Toll-Like receptor 7 agonist | 0.381 0.068 DB00154 0.407 0.057 DBMET02087 0.243 0.153 DBMET02086 0.381 0.068 DB04557 0.269 0.132 DB00917 | DBMET02087 | |
| 0.327 | 0.016 | 0.55 | Interferon gamma antagonist | 0.327 0.016 DB00154 0.381 0.012 DBMET02087 0.55 0.004 DBMET02086 0.327 0.016 DB04557 0.524 0.005 DB00917 | DBMET02086 | |
| 0.324 | 0.015 | 0.418 | Bone formation stimulant | 0.324 0.015 DB00154 0.371 0.011 DBMET02087 0.418 0.009 DBMET02086 0.324 0.015 DB04557 0.405 0.01 DB00917 | DBMET02086 | |
| 0.327 | 0.02 | 0.327 | Thrombolytic | 0.327 0.02 DB00154 0.285 0.026 DBMET02087 0.19 0.057 DBMET02086 0.327 0.02 DB04557 0.15 0.082 DB00917 | ||
| 0.306 | 0.003 | 0.306 | Fumarate hydratase inhibitor | 0.306 0.003 DB00154 0.207 0.003 DBMET02087 0.053 0.012 DBMET02086 0.306 0.003 DB04557 0.04 0.018 DB00917 | ||
| 0.311 | 0.009 | 0.311 | Cystathionine beta-synthase inhibitor | 0.311 0.009 DB00154 0.16 0.036 DBMET02087 0.311 0.009 DB04557 | ||
| 0.336 | 0.034 | 0.336 | Psychostimulant | 0.336 0.034 DB00154 0.152 0.114 DBMET02087 0.336 0.034 DB04557 | ||
| 0.337 | 0.039 | 0.337 | Insulysin inhibitor | 0.337 0.039 DB00154 0.24 0.106 DBMET02087 0.337 0.039 DB04557 | ||
| 0.299 | 0.002 | 0.905 | Prostaglandin agonist | 0.299 0.002 DB00154 0.412 0.001 DBMET02087 0.794 0 DBMET02086 0.299 0.002 DB04557 0.905 0 DB00917 | DB00917 | |
| 0.314 | 0.019 | 0.314 | Lipocortins synthesis antagonist | 0.314 0.019 DB00154 0.223 0.044 DBMET02087 0.242 0.036 DBMET02086 0.314 0.019 DB04557 0.224 0.043 DB00917 | ||
| 0.303 | 0.011 | 0.407 | Cholesterol synthesis inhibitor | 0.303 0.011 DB00154 0.284 0.013 DBMET02087 0.407 0.004 DBMET02086 0.303 0.011 DB04557 0.376 0.005 DB00917 | DBMET02086 | |
| 0.307 | 0.021 | 0.307 | Diuretic | 0.307 0.021 DB00154 0.179 0.054 DBMET02087 0.307 0.021 DB04557 | ||
| 0.298 | 0.013 | 0.391 | Alkylator | 0.298 0.013 DB00154 0.391 0.008 DBMET02087 0.298 0.013 DB04557 0.125 0.063 DB00917 | DBMET02087 | |
| 0.343 | 0.06 | 0.343 | 12-Lipoxygenase inhibitor | 0.343 0.06 DB00154 0.178 0.175 DBMET02087 0.343 0.06 DB04557 | ||
| 0.285 | 0.002 | 0.285 | Arachidonic acid antagonist | 0.285 0.002 DB00154 0.267 0.004 DBMET02087 0.222 0.016 DBMET02086 0.285 0.002 DB04557 0.232 0.011 DB00917 | ||
| 0.306 | 0.024 | 0.306 | DNA methyltransferase I inhibitor | 0.306 0.024 DB00154 0.294 0.028 DBMET02087 0.306 0.024 DB04557 | ||
| 0.296 | 0.015 | 0.322 | Antipruritic | 0.296 0.015 DB00154 0.322 0.011 DBMET02087 0.283 0.017 DBMET02086 0.296 0.015 DB04557 0.228 0.033 DB00917 | DBMET02087 | |
| 0.285 | 0.004 | 0.498 | Leukotriene antagonist | 0.285 0.004 DB00154 0.498 0.002 DBMET02087 0.276 0.004 DBMET02086 0.285 0.004 DB04557 0.272 0.004 DB00917 | DBMET02087 | |
| 0.326 | 0.045 | 0.326 | Free radical scavenger | 0.326 0.045 DB00154 0.261 0.064 DBMET02087 0.202 0.096 DBMET02086 0.326 0.045 DB04557 0.199 0.099 DB00917 | ||
| 0.317 | 0.037 | 0.381 | Nitric oxide antagonist | 0.317 0.037 DB00154 0.381 0.028 DBMET02087 0.333 0.034 DBMET02086 0.317 0.037 DB04557 0.37 0.029 DB00917 | DBMET02087 | |
| 0.282 | 0.005 | 0.282 | Photosensitizer | 0.282 0.005 DB00154 0.152 0.03 DBMET02087 0.171 0.021 DBMET02086 0.282 0.005 DB04557 0.098 0.092 DB00917 | ||
| 0.275 | 0.003 | 0.331 | Adenylate cyclase stimulant | 0.275 0.003 DB00154 0.306 0.003 DBMET02087 0.331 0.002 DBMET02086 0.275 0.003 DB04557 0.329 0.002 DB00917 | DBMET02086 | |
| 0.275 | 0.005 | 0.275 | Cell adhesion molecule inhibitor | 0.275 0.005 DB00154 0.257 0.006 DBMET02087 0.275 0.005 DB04557 | ||
| 0.281 | 0.011 | 0.318 | Cell wall synthesis inhibitor | 0.281 0.011 DB00154 0.318 0.009 DBMET02087 0.281 0.011 DB04557 | DBMET02087 | |
| 0.289 | 0.021 | 0.289 | Neurotrophic factor enhancer | 0.289 0.021 DB00154 0.244 0.042 DBMET02087 0.289 0.021 DB04557 | ||
| 0.268 | 0.005 | 0.268 | GABA C receptor antagonist | 0.268 0.005 DB00154 0.164 0.024 DBMET02087 0.268 0.005 DB04557 | ||
| 0.267 | 0.005 | 0.267 | Carbamoyl phosphate synthetase inhibitor | 0.267 0.005 DB00154 0.213 0.007 DBMET02087 0.09 0.024 DBMET02086 0.267 0.005 DB04557 0.07 0.034 DB00917 | ||
| 0.265 | 0.004 | 0.265 | Thioredoxin inhibitor | 0.265 0.004 DB00154 0.168 0.013 DBMET02087 0.265 0.004 DB04557 0.086 0.069 DB00917 | ||
| 0.274 | 0.013 | 0.274 | Protein-tyrosine phosphatase 1B inhibitor | 0.274 0.013 DB00154 0.25 0.017 DBMET02087 0.091 0.088 DBMET02086 0.274 0.013 DB04557 | ||
| 0.326 | 0.068 | 0.326 | Vasodilator, coronary | 0.326 0.068 DB00154 0.291 0.095 DBMET02087 0.284 0.101 DBMET02086 0.326 0.068 DB04557 | ||
| 0.26 | 0.003 | 0.26 | Acyl-CoA dehydrogenase inhibitor | 0.26 0.003 DB00154 0.258 0.003 DBMET02087 0.092 0.018 DBMET02086 0.26 0.003 DB04557 0.111 0.014 DB00917 | ||
| 0.256 | 0.003 | 0.268 | Thromboxane synthase inhibitor | 0.256 0.003 DB00154 0.268 0.003 DBMET02087 0.109 0.005 DBMET02086 0.256 0.003 DB04557 0.174 0.004 DB00917 | DBMET02087 | |
| 0.255 | 0.005 | 0.255 | Argininosuccinate synthase inhibitor | 0.255 0.005 DB00154 0.129 0.014 DBMET02087 0.069 0.031 DBMET02086 0.255 0.005 DB04557 0.051 0.046 DB00917 | ||
| 0.246 | 0.004 | 0.246 | CDC25A inhibitor | 0.246 0.004 DB00154 0.194 0.007 DBMET02087 0.109 0.023 DBMET02086 0.246 0.004 DB04557 0.118 0.02 DB00917 | ||
| 0.275 | 0.036 | 0.275 | DNA methylase inhibitor | 0.275 0.036 DB00154 0.258 0.044 DBMET02087 0.275 0.036 DB04557 | ||
| 0.24 | 0.003 | 0.24 | Sphingosine 1-phosphate receptor 4 agonist | 0.24 0.003 DB00154 0.179 0.005 DBMET02087 0.24 0.003 DB04557 | ||
| 0.248 | 0.013 | 0.424 | Expectorant | 0.248 0.013 DB00154 0.424 0.004 DBMET02087 0.153 0.034 DBMET02086 0.248 0.013 DB04557 0.158 0.032 DB00917 | DBMET02087 | |
| 0.239 | 0.003 | 0.667 | Thromboxane antagonist | 0.239 0.003 DB00154 0.275 0.003 DBMET02087 0.51 0.002 DBMET02086 0.239 0.003 DB04557 0.667 0.001 DB00917 | DB00917 | |
| 0.268 | 0.035 | 0.268 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.268 0.035 DB00154 0.154 0.139 DBMET02087 0.268 0.035 DB04557 | ||
| 0.29 | 0.058 | 0.359 | Transcription factor STAT3 inhibitor | 0.29 0.058 DB00154 0.204 0.128 DBMET02087 0.272 0.068 DBMET02086 0.29 0.058 DB04557 0.359 0.03 DB00917 | DB00917 | |
| 0.234 | 0.003 | 0.234 | Glycine receptor agonist | 0.234 0.003 DB00154 0.126 0.011 DBMET02087 0.083 0.035 DBMET02086 0.234 0.003 DB04557 0.07 0.054 DB00917 | ||
| 0.257 | 0.026 | 0.257 | Amylase inhibitor | 0.257 0.026 DB00154 0.19 0.048 DBMET02087 0.257 0.026 DB04557 | ||
| 0.234 | 0.004 | 0.234 | Sphingosine 1-phosphate receptor 2 antagonist | 0.234 0.004 DB00154 0.186 0.012 DBMET02087 0.234 0.004 DB04557 | ||
| 0.234 | 0.005 | 0.248 | Leukotriene synthesis inhibitor | 0.234 0.005 DB00154 0.248 0.005 DBMET02087 0.111 0.02 DBMET02086 0.234 0.005 DB04557 0.122 0.016 DB00917 | DBMET02087 | |
| 0.233 | 0.004 | 0.233 | Ornithine decarboxylase inhibitor | 0.233 0.004 DB00154 0.189 0.005 DBMET02087 0.128 0.02 DBMET02086 0.233 0.004 DB04557 0.127 0.021 DB00917 | ||
| 0.231 | 0.003 | 0.231 | Vanilloid 2 antagonist | 0.231 0.003 DB00154 0.143 0.004 DBMET02087 0.231 0.003 DB04557 0.057 0.027 DB00917 | ||
| 0.289 | 0.062 | 0.289 | Transcription factor STAT inhibitor | 0.289 0.062 DB00154 0.178 0.172 DBMET02087 0.209 0.126 DBMET02086 0.289 0.062 DB04557 0.288 0.063 DB00917 | ||
| 0.23 | 0.006 | 0.23 | Keratolytic | 0.23 0.006 DB00154 0.179 0.01 DBMET02087 0.23 0.006 DB04557 0.071 0.064 DB00917 | ||
| 0.232 | 0.008 | 0.35 | Mucolytic | 0.232 0.008 DB00154 0.35 0.004 DBMET02087 0.145 0.035 DBMET02086 0.232 0.008 DB04557 0.152 0.031 DB00917 | DBMET02087 | |
| 0.227 | 0.005 | 0.227 | Sphingosine 1-phosphate receptor 5 antagonist | 0.227 0.005 DB00154 0.185 0.02 DBMET02087 0.227 0.005 DB04557 | ||
| 0.226 | 0.005 | 0.226 | GABA C receptor rho-1 antagonist | 0.226 0.005 DB00154 0.151 0.021 DBMET02087 0.226 0.005 DB04557 | ||
| 0.223 | 0.002 | 0.223 | Ca2+-transporting ATPase inhibitor | 0.223 0.002 DB00154 0.191 0.004 DBMET02087 0.164 0.019 DBMET02086 0.223 0.002 DB04557 0.155 0.033 DB00917 | ||
| 0.229 | 0.009 | 0.229 | Alcohol dehydrogenase inhibitor | 0.229 0.009 DB00154 0.109 0.043 DBMET02087 0.229 0.009 DB04557 | ||
| 0.224 | 0.006 | 0.231 | Toll-Like receptor 2 agonist | 0.224 0.006 DB00154 0.231 0.005 DBMET02087 0.035 0.034 DBMET02086 0.224 0.006 DB04557 0.041 0.028 DB00917 | DBMET02087 | |
| 0.217 | 0.003 | 0.53 | Thromboxane A2 antagonist | 0.217 0.003 DB00154 0.252 0.003 DBMET02087 0.381 0.002 DBMET02086 0.217 0.003 DB04557 0.53 0.002 DB00917 | DB00917 | |
| 0.213 | 0.003 | 0.471 | Leukotriene B4 antagonist | 0.213 0.003 DB00154 0.471 0.002 DBMET02087 0.234 0.003 DBMET02086 0.213 0.003 DB04557 0.212 0.003 DB00917 | DBMET02087 | |
| 0.235 | 0.026 | 0.294 | Interleukin 6 antagonist | 0.235 0.026 DB00154 0.294 0.015 DBMET02087 0.235 0.026 DB04557 0.184 0.052 DB00917 | DBMET02087 | |
| 0.216 | 0.008 | 0.26 | Folate antagonist | 0.216 0.008 DB00154 0.26 0.004 DBMET02087 0.12 0.039 DBMET02086 0.216 0.008 DB04557 0.103 0.059 DB00917 | DBMET02087 | |
| 0.225 | 0.016 | 0.225 | Aminopeptidase B inhibitor | 0.225 0.016 DB00154 0.186 0.025 DBMET02087 0.225 0.016 DB04557 | ||
| 0.222 | 0.015 | 0.263 | Microtubule formation inhibitor | 0.222 0.015 DB00154 0.263 0.005 DBMET02087 0.246 0.01 DBMET02086 0.222 0.015 DB04557 0.257 0.007 DB00917 | DBMET02087 | |
| 0.226 | 0.021 | 0.274 | ATPase inhibitor | 0.226 0.021 DB00154 0.274 0.009 DBMET02087 0.233 0.018 DBMET02086 0.226 0.021 DB04557 0.249 0.014 DB00917 | DBMET02087 | |
| 0.206 | 0.004 | 0.206 | Acetyl-CoA transferase inhibitor | 0.206 0.004 DB00154 0.119 0.009 DBMET02087 0.206 0.004 DB04557 | ||
| 0.206 | 0.004 | 0.206 | Peroxisome proliferator-activated receptor alpha agonist | 0.206 0.004 DB00154 0.181 0.005 DBMET02087 0.068 0.023 DBMET02086 0.206 0.004 DB04557 0.044 0.037 DB00917 | ||
| 0.209 | 0.008 | 0.209 | Sphingosine 1-phosphate receptor 4 antagonist | 0.209 0.008 DB00154 0.165 0.022 DBMET02087 0.209 0.008 DB04557 | ||
| 0.217 | 0.021 | 0.382 | Neurotrophic factor | 0.217 0.021 DB00154 0.313 0.007 DBMET02087 0.382 0.005 DBMET02086 0.217 0.021 DB04557 0.333 0.006 DB00917 | DBMET02086 | |
| 0.2 | 0.004 | 0.2 | Leukotriene D4 antagonist | 0.2 0.004 DB00154 0.176 0.004 DBMET02087 0.2 0.004 DB04557 | ||
| 0.203 | 0.008 | 0.203 | Electrolyte absorption antagonist | 0.203 0.008 DB00154 0.138 0.025 DBMET02087 0.203 0.008 DB04557 | ||
| 0.212 | 0.018 | 0.212 | Farnesoid X receptor antagonist | 0.212 0.018 DB00154 0.142 0.063 DBMET02087 0.132 0.078 DBMET02086 0.212 0.018 DB04557 0.163 0.04 DB00917 | ||
| 0.196 | 0.002 | 0.196 | Lysophosphatidic acid 3 receptor antagonist | 0.196 0.002 DB00154 0.161 0.002 DBMET02087 0.196 0.002 DB04557 0.055 0.029 DB00917 | ||
| 0.219 | 0.027 | 0.639 | Hemostatic | 0.219 0.027 DB00154 0.202 0.032 DBMET02087 0.525 0.004 DBMET02086 0.219 0.027 DB04557 0.639 0.003 DB00917 | DB00917 | |
| 0.201 | 0.009 | 0.252 | Sphingomyelinase inhibitor | 0.201 0.009 DB00154 0.252 0.004 DBMET02087 0.095 0.066 DBMET02086 0.201 0.009 DB04557 0.11 0.049 DB00917 | DBMET02087 | |
| 0.193 | 0.003 | 0.885 | Prostaglandin E2 agonist | 0.193 0.003 DB00154 0.346 0.002 DBMET02087 0.775 0 DBMET02086 0.193 0.003 DB04557 0.885 0 DB00917 | DB00917 | |
| 0.2 | 0.009 | 0.2 | Caspase 3 inhibitor | 0.2 0.009 DB00154 0.129 0.048 DBMET02087 0.2 0.009 DB04557 | ||
| 0.2 | 0.01 | 0.2 | Creatine kinase inhibitor | 0.2 0.01 DB00154 0.099 0.06 DBMET02087 0.2 0.01 DB04557 | ||
| 0.192 | 0.002 | 0.192 | Glucose-6-phosphate isomerase inhibitor | 0.192 0.002 DB00154 0.171 0.002 DBMET02087 0.098 0.005 DBMET02086 0.192 0.002 DB04557 0.085 0.007 DB00917 | ||
| 0.203 | 0.013 | 0.203 | Calcium antagonist | 0.203 0.013 DB00154 0.125 0.032 DBMET02087 0.203 0.013 DB04557 | ||
| 0.2 | 0.011 | 0.224 | Selectin antagonist | 0.2 0.011 DB00154 0.224 0.009 DBMET02087 0.061 0.049 DBMET02086 0.2 0.011 DB04557 0.071 0.042 DB00917 | DBMET02087 | |
| 0.194 | 0.006 | 0.194 | Amidase inhibitor | 0.194 0.006 DB00154 0.129 0.013 DBMET02087 0.194 0.006 DB04557 | ||
| 0.192 | 0.005 | 0.192 | Anabolic | 0.192 0.005 DB00154 0.177 0.008 DBMET02087 0.184 0.006 DBMET02086 0.192 0.005 DB04557 0.177 0.008 DB00917 | ||
| 0.193 | 0.007 | 0.193 | Toll-Like receptor 4 antagonist | 0.193 0.007 DB00154 0.189 0.008 DBMET02087 0.16 0.016 DBMET02086 0.193 0.007 DB04557 0.166 0.014 DB00917 | ||
| 0.197 | 0.011 | 0.197 | AMP-activated protein kinase stimulant | 0.197 0.011 DB00154 0.142 0.033 DBMET02087 0.197 0.011 DB04557 | ||
| 0.191 | 0.006 | 0.192 | Interferon agonist | 0.191 0.006 DB00154 0.192 0.006 DBMET02087 0.114 0.02 DBMET02086 0.191 0.006 DB04557 0.074 0.062 DB00917 | DBMET02087 | |
| 0.194 | 0.01 | 0.194 | Antimetabolite | 0.194 0.01 DB00154 0.14 0.013 DBMET02087 0.194 0.01 DB04557 | ||
| 0.19 | 0.006 | 0.19 | Biliverdin reductase inhibitor | 0.19 0.006 DB00154 0.134 0.011 DBMET02087 0.19 0.006 DB04557 | ||
| 0.188 | 0.004 | 0.188 | Sphingosine 1-phosphate receptor 5 agonist | 0.188 0.004 DB00154 0.118 0.006 DBMET02087 0.055 0.034 DBMET02086 0.188 0.004 DB04557 | ||
| 0.207 | 0.025 | 0.207 | GABA C receptor rho-2 antagonist | 0.207 0.025 DB00154 0.207 0.025 DB04557 | ||
| 0.185 | 0.007 | 0.185 | Ornithine carbamoyltransferase inhibitor | 0.185 0.007 DB00154 0.126 0.012 DBMET02087 0.185 0.007 DB04557 | ||
| 0.183 | 0.005 | 0.183 | CDC25B inhibitor | 0.183 0.005 DB00154 0.092 0.02 DBMET02087 0.183 0.005 DB04557 | ||
| 0.195 | 0.017 | 0.195 | Carbonic anhydrase III inhibitor | 0.195 0.017 DB00154 0.195 0.017 DB04557 | ||
| 0.187 | 0.01 | 0.461 | Electron transport complex I inhibitor | 0.187 0.01 DB00154 0.461 0.004 DBMET02087 0.169 0.013 DBMET02086 0.187 0.01 DB04557 0.155 0.018 DB00917 | DBMET02087 | |
| 0.191 | 0.014 | 0.728 | Gastric antisecretory | 0.191 0.014 DB00154 0.221 0.009 DBMET02087 0.615 0.002 DBMET02086 0.191 0.014 DB04557 0.728 0.002 DB00917 | DB00917 | |
| 0.208 | 0.031 | 0.208 | Neurotensin receptor agonist | 0.208 0.031 DB00154 0.148 0.107 DBMET02087 0.208 0.031 DB04557 | ||
| 0.18 | 0.005 | 0.18 | GABA aminotransferase inhibitor | 0.18 0.005 DB00154 0.103 0.025 DBMET02087 0.083 0.043 DBMET02086 0.18 0.005 DB04557 | ||
| 0.178 | 0.005 | 0.178 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.178 0.005 DB00154 0.109 0.014 DBMET02087 0.178 0.005 DB04557 | ||
| 0.195 | 0.023 | 0.195 | Antibacterial (Helicobacter pylori) | 0.195 0.023 DB00154 0.149 0.047 DBMET02087 0.195 0.023 DB04557 | ||
| 0.193 | 0.024 | 0.193 | Cathepsin H inhibitor | 0.193 0.024 DB00154 0.148 0.048 DBMET02087 0.193 0.024 DB04557 | ||
| 0.173 | 0.004 | 0.173 | Glycine receptor antagonist | 0.173 0.004 DB00154 0.111 0.023 DBMET02087 0.083 0.052 DBMET02086 0.173 0.004 DB04557 | ||
| 0.216 | 0.048 | 0.216 | Dual specificity phosphatase inhibitor | 0.216 0.048 DB00154 0.216 0.048 DB04557 | ||
| 0.185 | 0.018 | 0.232 | Potassium channel (Ca-activated) activator | 0.185 0.018 DB00154 0.232 0.009 DBMET02087 0.185 0.018 DB04557 | DBMET02087 | |
| 0.19 | 0.023 | 0.19 | Cyclooxygenase 3 inhibitor | 0.19 0.023 DB00154 0.126 0.071 DBMET02087 0.19 0.023 DB04557 | ||
| 0.17 | 0.003 | 0.17 | Glutamate (mGluR6) antagonist | 0.17 0.003 DB00154 0.1 0.01 DBMET02087 0.08 0.024 DBMET02086 0.17 0.003 DB04557 0.064 0.055 DB00917 | ||
| 0.164 | 0.003 | 0.164 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.164 0.003 DB00154 0.065 0.005 DBMET02087 0.164 0.003 DB04557 | ||
| 0.168 | 0.007 | 0.168 | Lanosterol 14 alpha demethylase inhibitor | 0.168 0.007 DB00154 0.142 0.015 DBMET02087 0.168 0.007 DB04557 | ||
| 0.159 | 0.005 | 0.213 | Oleamide hydrolase inhibitor | 0.159 0.005 DB00154 0.213 0.004 DBMET02087 0.159 0.005 DB04557 | DBMET02087 | |
| 0.155 | 0.002 | 0.614 | Prostaglandin D2 agonist | 0.155 0.002 DB00154 0.275 0.002 DBMET02087 0.539 0.001 DBMET02086 0.155 0.002 DB04557 0.614 0.001 DB00917 | DB00917 | |
| 0.158 | 0.007 | 0.158 | NMDA receptor agonist | 0.158 0.007 DB00154 0.057 0.052 DBMET02087 0.158 0.007 DB04557 | ||
| 0.153 | 0.002 | 0.153 | Leukotriene C antagonist | 0.153 0.002 DB00154 0.139 0.003 DBMET02087 0.069 0.015 DBMET02086 0.153 0.002 DB04557 0.067 0.017 DB00917 | ||
| 0.152 | 0.004 | 0.872 | Prostaglandin EP4 antagonist | 0.152 0.004 DB00154 0.224 0.003 DBMET02087 0.829 0.001 DBMET02086 0.152 0.004 DB04557 0.872 0.001 DB00917 | DB00917 | |
| 0.269 | 0.125 | 0.269 | Calcium channel activator | 0.269 0.125 DB00154 0.269 0.125 DB04557 | ||
| 0.147 | 0.002 | 0.147 | Kainate receptor agonist | 0.147 0.002 DB00154 0.091 0.003 DBMET02087 0.044 0.022 DBMET02086 0.147 0.002 DB04557 0.05 0.014 DB00917 | ||
| 0.154 | 0.01 | 0.226 | Potassium channel large-conductance Ca-activated activator | 0.154 0.01 DB00154 0.226 0.005 DBMET02087 0.154 0.01 DB04557 | DBMET02087 | |
| 0.147 | 0.003 | 0.147 | Retinoid X alpha receptor agonist | 0.147 0.003 DB00154 0.092 0.006 DBMET02087 0.147 0.003 DB04557 | ||
| 0.148 | 0.004 | 0.62 | Prostaglandin EP3 antagonist | 0.148 0.004 DB00154 0.224 0.004 DBMET02087 0.577 0.001 DBMET02086 0.148 0.004 DB04557 0.62 0.001 DB00917 | DB00917 | |
| 0.143 | 0.004 | 0.162 | Vanilloid 4 agonist | 0.143 0.004 DB00154 0.162 0.003 DBMET02087 0.096 0.02 DBMET02086 0.143 0.004 DB04557 0.086 0.031 DB00917 | DBMET02087 | |
| 0.151 | 0.012 | 0.151 | Aminopeptidase I inhibitor | 0.151 0.012 DB00154 0.13 0.017 DBMET02087 0.151 0.012 DB04557 | ||
| 0.224 | 0.084 | 0.224 | Antiamyloidogenic | 0.224 0.084 DB00154 0.173 0.12 DBMET02087 0.224 0.084 DB04557 | ||
| 0.141 | 0.002 | 0.64 | Prostaglandin EP4 agonist | 0.141 0.002 DB00154 0.175 0.002 DBMET02087 0.511 0 DBMET02086 0.141 0.002 DB04557 0.64 0 DB00917 | DB00917 | |
| 0.139 | 0.002 | 0.139 | Membrane dipeptidase inhibitor | 0.139 0.002 DB00154 0.099 0.004 DBMET02087 0.058 0.011 DBMET02086 0.139 0.002 DB04557 0.057 0.011 DB00917 | ||
| 0.14 | 0.004 | 0.14 | Phospholipase D inhibitor | 0.14 0.004 DB00154 0.099 0.015 DBMET02087 0.14 0.004 DB04557 | ||
| 0.218 | 0.082 | 0.218 | Cyclic AMP phosphodiesterase inhibitor | 0.218 0.082 DB00154 0.158 0.139 DBMET02087 0.218 0.082 DB04557 | ||
| 0.141 | 0.005 | 0.141 | Kainate receptor antagonist | 0.141 0.005 DB00154 0.042 0.027 DBMET02087 0.141 0.005 DB04557 | ||
| 0.14 | 0.004 | 0.14 | Prostaglandin D2 antagonist | 0.14 0.004 DB00154 0.03 0.011 DBMET02087 0.14 0.004 DB04557 0.057 0.006 DB00917 | ||
| 0.161 | 0.027 | 0.161 | Heat shock protein 70 antagonist | 0.161 0.027 DB00154 0.161 0.027 DB04557 | ||
| 0.136 | 0.003 | 0.516 | Prostacyclin agonist | 0.136 0.003 DB00154 0.234 0.002 DBMET02087 0.47 0.001 DBMET02086 0.136 0.003 DB04557 0.516 0.001 DB00917 | DB00917 | |
| 0.14 | 0.007 | 0.14 | Peroxisome proliferator-activated receptor gamma antagonist | 0.14 0.007 DB00154 0.121 0.009 DBMET02087 0.14 0.007 DB04557 | ||
| 0.145 | 0.013 | 0.145 | Glutathione S-transferase inhibitor | 0.145 0.013 DB00154 0.081 0.06 DBMET02087 0.145 0.013 DB04557 | ||
| 0.226 | 0.096 | 0.226 | DNA damaging | 0.226 0.096 DB00154 0.226 0.096 DB04557 | ||
| 0.139 | 0.01 | 0.139 | Bile acid receptor antagonist | 0.139 0.01 DB00154 0.099 0.05 DBMET02087 0.091 0.071 DBMET02086 0.139 0.01 DB04557 | ||
| 0.142 | 0.013 | 0.142 | Phenylalanine 4-hydroxylase inhibitor | 0.142 0.013 DB00154 0.107 0.023 DBMET02087 0.142 0.013 DB04557 | ||
| 0.139 | 0.013 | 0.139 | Ribonucleoside-diphosphate reductase inhibitor | 0.139 0.013 DB00154 0.125 0.015 DBMET02087 0.139 0.013 DB04557 | ||
| 0.145 | 0.019 | 0.145 | NADH dehydrogenase inhibitor | 0.145 0.019 DB00154 0.115 0.031 DBMET02087 0.145 0.019 DB04557 | ||
| 0.194 | 0.069 | 0.233 | Growth factor agonist | 0.194 0.069 DB00154 0.233 0.04 DBMET02087 0.194 0.069 DB04557 | DBMET02087 | |
| 0.127 | 0.002 | 0.824 | Prostaglandin EP2 agonist | 0.127 0.002 DB00154 0.2 0.002 DBMET02087 0.689 0 DBMET02086 0.127 0.002 DB04557 0.824 0 DB00917 | DB00917 | |
| 0.127 | 0.002 | 0.127 | Leukotriene C4 antagonist | 0.127 0.002 DB00154 0.107 0.003 DBMET02087 0.045 0.015 DBMET02086 0.127 0.002 DB04557 0.043 0.017 DB00917 | ||
| 0.127 | 0.003 | 0.127 | Retinoid X receptor agonist | 0.127 0.003 DB00154 0.091 0.005 DBMET02087 0.127 0.003 DB04557 | ||
| 0.145 | 0.022 | 0.145 | Cathepsin G inhibitor | 0.145 0.022 DB00154 0.073 0.05 DBMET02087 0.145 0.022 DB04557 | ||
| 0.124 | 0.001 | 0.124 | Lysophosphatidic acid receptor 1 agonist | 0.124 0.001 DB00154 0.099 0.002 DBMET02087 0.025 0.017 DBMET02086 0.124 0.001 DB04557 0.026 0.016 DB00917 | ||
| 0.21 | 0.087 | 0.23 | Peptidyltransferase inhibitor | 0.21 0.087 DB00154 0.181 0.127 DBMET02087 0.23 0.067 DBMET02086 0.21 0.087 DB04557 0.184 0.122 DB00917 | DBMET02086 | |
| 0.135 | 0.014 | 0.135 | Ribonucleotide reductase inhibitor | 0.135 0.014 DB00154 0.122 0.016 DBMET02087 0.135 0.014 DB04557 | ||
| 0.126 | 0.006 | 0.126 | GABA B receptor agonist | 0.126 0.006 DB00154 0.09 0.025 DBMET02087 0.126 0.006 DB04557 | ||
| 0.121 | 0.003 | 0.121 | G-protein-coupled receptor 120 agonist | 0.121 0.003 DB00154 0.047 0.004 DBMET02087 0.121 0.003 DB04557 | ||
| 0.125 | 0.007 | 0.125 | Interferon inducer | 0.125 0.007 DB00154 0.124 0.007 DBMET02087 0.084 0.021 DBMET02086 0.125 0.007 DB04557 | ||
| 0.129 | 0.013 | 0.129 | Cannabinoid CB1 receptor agonist | 0.129 0.013 DB00154 0.129 0.013 DB04557 | ||
| 0.138 | 0.023 | 0.138 | Interleukin 1 beta converting enzyme inhibitor | 0.138 0.023 DB00154 0.138 0.023 DB04557 | ||
| 0.143 | 0.028 | 0.143 | HIV-1 integrase (Overall Integration) inhibitor | 0.143 0.028 DB00154 0.143 0.028 DB04557 | ||
| 0.129 | 0.014 | 0.129 | Lipase inhibitor | 0.129 0.014 DB00154 0.11 0.022 DBMET02087 0.129 0.014 DB04557 | ||
| 0.139 | 0.028 | 0.139 | DOPA decarboxylase inhibitor | 0.139 0.028 DB00154 0.139 0.028 DB04557 | ||
| 0.112 | 0.001 | 0.718 | Prostaglandin F2 alpha agonist | 0.112 0.001 DB00154 0.13 0.001 DBMET02087 0.522 0 DBMET02086 0.112 0.001 DB04557 0.718 0 DB00917 | DB00917 | |
| 0.113 | 0.003 | 0.118 | ATP citrate lysase inhibitor | 0.113 0.003 DB00154 0.118 0.003 DBMET02087 0.11 0.003 DBMET02086 0.113 0.003 DB04557 0.052 0.007 DB00917 | DBMET02087 | |
| 0.113 | 0.004 | 0.113 | Peroxisome proliferator-activated receptor alpha antagonist | 0.113 0.004 DB00154 0.042 0.009 DBMET02087 0.113 0.004 DB04557 | ||
| 0.113 | 0.004 | 0.598 | Prostacyclin antagonist | 0.113 0.004 DB00154 0.158 0.004 DBMET02087 0.454 0.002 DBMET02086 0.113 0.004 DB04557 0.598 0.002 DB00917 | DB00917 | |
| 0.12 | 0.012 | 0.12 | Elastase 1 inhibitor | 0.12 0.012 DB00154 0.076 0.04 DBMET02087 0.12 0.012 DB04557 0.062 0.058 DB00917 | ||
| 0.116 | 0.008 | 0.116 | Plasminogen activator inhibitor antagonist | 0.116 0.008 DB00154 0.046 0.038 DBMET02087 0.116 0.008 DB04557 | ||
| 0.131 | 0.023 | 0.131 | Histidine decarboxylase inhibitor | 0.131 0.023 DB00154 0.072 0.049 DBMET02087 0.131 0.023 DB04557 | ||
| 0.111 | 0.004 | 0.111 | Kainate receptor 2 antagonist | 0.111 0.004 DB00154 0.036 0.025 DBMET02087 0.111 0.004 DB04557 | ||
| 0.11 | 0.004 | 0.11 | Acetyl-CoA transferase 1 inhibitor | 0.11 0.004 DB00154 0.061 0.009 DBMET02087 0.11 0.004 DB04557 | ||
| 0.11 | 0.005 | 0.11 | Squalene synthetase inhibitor | 0.11 0.005 DB00154 0.084 0.008 DBMET02087 0.035 0.02 DBMET02086 0.11 0.005 DB04557 0.037 0.019 DB00917 | ||
| 0.109 | 0.005 | 0.109 | Peroxisome proliferator-activated receptor delta agonist | 0.109 0.005 DB00154 0.088 0.007 DBMET02087 0.109 0.005 DB04557 | ||
| 0.142 | 0.039 | 0.142 | Interleukin 8 antagonist | 0.142 0.039 DB00154 0.142 0.039 DB04557 | ||
| 0.137 | 0.034 | 0.137 | UDP-glucose 4-epimerase inhibitor | 0.137 0.034 DB00154 0.104 0.057 DBMET02087 0.137 0.034 DB04557 | ||
| 0.181 | 0.079 | 0.224 | P-glycoprotein inhibitor | 0.181 0.079 DB00154 0.224 0.051 DBMET02087 0.187 0.074 DBMET02086 0.181 0.079 DB04557 0.183 0.077 DB00917 | DBMET02087 | |
| 0.11 | 0.009 | 0.11 | Fatty acid synthase inhibitor | 0.11 0.009 DB00154 0.057 0.039 DBMET02087 0.11 0.009 DB04557 | ||
| 0.14 | 0.04 | 0.14 | Chelator | 0.14 0.04 DB00154 0.14 0.04 DB04557 | ||
| 0.161 | 0.06 | 0.161 | Thiol protease inhibitor | 0.161 0.06 DB00154 0.141 0.079 DBMET02087 0.161 0.06 DB04557 | ||
| 0.112 | 0.013 | 0.805 | Prostaglandin E2 antagonist | 0.112 0.013 DB00154 0.162 0.008 DBMET02087 0.75 0.002 DBMET02086 0.112 0.013 DB04557 0.805 0.002 DB00917 | DB00917 | |
| 0.101 | 0.001 | 0.101 | Lysophosphatidic acid receptor 3 agonist | 0.101 0.001 DB00154 0.081 0.002 DBMET02087 0.101 0.001 DB04557 | ||
| 0.102 | 0.004 | 0.252 | Leukotriene B4 receptor 1 antagonist | 0.102 0.004 DB00154 0.252 0.003 DBMET02087 0.084 0.004 DBMET02086 0.102 0.004 DB04557 0.068 0.005 DB00917 | DBMET02087 | |
| 0.117 | 0.018 | 0.132 | Na+ K+ transporting ATPase inhibitor | 0.117 0.018 DB00154 0.127 0.013 DBMET02087 0.132 0.011 DBMET02086 0.117 0.018 DB04557 0.126 0.013 DB00917 | DBMET02086 | |
| 0.104 | 0.007 | 0.123 | Sphingosine kinase inhibitor | 0.104 0.007 DB00154 0.123 0.005 DBMET02087 0.106 0.006 DBMET02086 0.104 0.007 DB04557 0.083 0.014 DB00917 | DBMET02087 | |
| 0.162 | 0.065 | 0.348 | Hexokinase inhibitor | 0.162 0.065 DB00154 0.133 0.099 DBMET02087 0.225 0.024 DBMET02086 0.162 0.065 DB04557 0.348 0.006 DB00917 | DB00917 | |
| 0.12 | 0.022 | 0.12 | Glutamate release inhibitor | 0.12 0.022 DB00154 0.085 0.075 DBMET02087 0.12 0.022 DB04557 | ||
| 0.099 | 0.001 | 0.891 | Thromboxane agonist | 0.099 0.001 DB00154 0.124 0.001 DBMET02087 0.691 0 DBMET02086 0.099 0.001 DB04557 0.891 0 DB00917 | DB00917 | |
| 0.187 | 0.09 | 0.187 | Histone acetyltransferase inhibitor | 0.187 0.09 DB00154 0.187 0.09 DB04557 | ||
| 0.135 | 0.038 | 0.135 | Transcription factor STAT6 inhibitor | 0.135 0.038 DB00154 0.135 0.038 DB04557 | ||
| 0.104 | 0.008 | 0.104 | Sphingosine 1-phosphate receptor 1 antagonist | 0.104 0.008 DB00154 0.062 0.026 DBMET02087 0.104 0.008 DB04557 | ||
| 0.098 | 0.002 | 0.098 | Lysophosphatidic acid 1 receptor antagonist | 0.098 0.002 DB00154 0.058 0.004 DBMET02087 0.098 0.002 DB04557 | ||
| 0.205 | 0.11 | 0.205 | Neuropeptide Y2 antagonist | 0.205 0.11 DB00154 0.205 0.11 DB04557 | ||
| 0.122 | 0.027 | 0.122 | Interleukin 12 antagonist | 0.122 0.027 DB00154 0.103 0.049 DBMET02087 0.122 0.027 DB04557 | ||
| 0.186 | 0.094 | 0.186 | Anticonvulsant | 0.186 0.094 DB00154 0.186 0.094 DB04557 | ||
| 0.096 | 0.004 | 0.096 | Pregnane X receptor antagonist | 0.096 0.004 DB00154 0.064 0.023 DBMET02087 0.057 0.038 DBMET02086 0.096 0.004 DB04557 0.057 0.039 DB00917 | ||
| 0.108 | 0.017 | 0.108 | Estrogen-related receptor beta agonist | 0.108 0.017 DB00154 0.108 0.017 DB04557 | ||
| 0.099 | 0.008 | 0.099 | Sphingosine 1-phosphate receptor 3 antagonist | 0.099 0.008 DB00154 0.073 0.023 DBMET02087 0.099 0.008 DB04557 | ||
| 0.12 | 0.029 | 0.12 | Carbonic anhydrase VI inhibitor | 0.12 0.029 DB00154 0.12 0.029 DB04557 | ||
| 0.104 | 0.014 | 0.104 | Cannabinoid CB2 receptor antagonist | 0.104 0.014 DB00154 0.104 0.014 DB04557 | ||
| 0.107 | 0.018 | 0.107 | Sphingosine 1-phosphate receptor antagonist | 0.107 0.018 DB00154 0.107 0.018 DB04557 | ||
| 0.224 | 0.142 | 0.224 | Thyroid hormone antagonist | 0.224 0.142 DB00154 0.224 0.142 DB04557 | ||
| 0.147 | 0.064 | 0.147 | Histone deacetylase SIRT1 inhibitor | 0.147 0.064 DB00154 0.147 0.064 DB04557 | ||
| 0.11 | 0.028 | 0.145 | ATPase (Vacuolar H+) inhibitor | 0.11 0.028 DB00154 0.145 0.009 DBMET02087 0.134 0.012 DBMET02086 0.11 0.028 DB04557 0.142 0.01 DB00917 | DBMET02087 | |
| 0.098 | 0.017 | 0.098 | Purinergic P2X1 antagonist | 0.098 0.017 DB00154 0.098 0.017 DB04557 | ||
| 0.127 | 0.045 | 0.191 | Sphingosine 1-phosphate receptor 2 agonist | 0.127 0.045 DB00154 0.191 0.013 DBMET02087 0.127 0.045 DB04557 | DBMET02087 | |
| 0.165 | 0.084 | 0.165 | Dual specificity phosphatase 3 inhibitor | 0.165 0.084 DB00154 0.165 0.084 DB04557 | ||
| 0.088 | 0.008 | 0.088 | Acetyl-CoA transferase 2 inhibitor | 0.088 0.008 DB00154 0.064 0.024 DBMET02087 0.088 0.008 DB04557 | ||
| 0.108 | 0.029 | 0.197 | Hematopoietic | 0.108 0.029 DB00154 0.197 0.01 DBMET02087 0.104 0.032 DBMET02086 0.108 0.029 DB04557 0.087 0.055 DB00917 | DBMET02087 | |
| 0.144 | 0.064 | 0.144 | Pregnane X receptor agonist | 0.144 0.064 DB00154 0.144 0.064 DB04557 | ||
| 0.083 | 0.004 | 0.083 | Glutamate (mGluR8) agonist | 0.083 0.004 DB00154 0.046 0.015 DBMET02087 0.083 0.004 DB04557 | ||
| 0.094 | 0.015 | 0.094 | Glutamate (mGluR7) antagonist | 0.094 0.015 DB00154 0.094 0.015 DB04557 | ||
| 0.111 | 0.033 | 0.111 | Carbonic anhydrase XIII inhibitor | 0.111 0.033 DB00154 0.111 0.033 DB04557 | ||
| 0.082 | 0.004 | 0.082 | Kainate receptor 1 antagonist | 0.082 0.004 DB00154 0.02 0.015 DBMET02087 0.082 0.004 DB04557 | ||
| 0.088 | 0.011 | 0.088 | Sphingosine kinase 2 inhibitor | 0.088 0.011 DB00154 0.079 0.016 DBMET02087 0.088 0.011 DB04557 | ||
| 0.123 | 0.046 | 0.123 | Xanthine oxidase inhibitor | 0.123 0.046 DB00154 0.123 0.046 DB04557 | ||
| 0.091 | 0.015 | 0.091 | Autotaxin inhibitor | 0.091 0.015 DB00154 0.091 0.015 DB04557 | ||
| 0.084 | 0.008 | 0.084 | Mannosidase inhibitor | 0.084 0.008 DB00154 0.08 0.009 DBMET02087 0.055 0.021 DBMET02086 0.084 0.008 DB04557 | ||
| 0.08 | 0.005 | 0.08 | Geranyltranstransferase inhibitor | 0.08 0.005 DB00154 0.043 0.031 DBMET02087 0.08 0.005 DB04557 | ||
| 0.091 | 0.017 | 0.091 | Caspase 9 inhibitor | 0.091 0.017 DB00154 0.061 0.044 DBMET02087 0.091 0.017 DB04557 | ||
| 0.089 | 0.015 | 0.124 | Nitric oxide donor | 0.089 0.015 DB00154 0.104 0.007 DBMET02087 0.119 0.004 DBMET02086 0.089 0.015 DB04557 0.124 0.004 DB00917 | DB00917 | |
| 0.084 | 0.01 | 0.084 | Alpha-mannosidase inhibitor | 0.084 0.01 DB00154 0.07 0.017 DBMET02087 0.05 0.043 DBMET02086 0.084 0.01 DB04557 | ||
| 0.132 | 0.059 | 0.132 | Anesthetic local | 0.132 0.059 DB00154 0.093 0.09 DBMET02087 0.132 0.059 DB04557 | ||
| 0.082 | 0.009 | 0.082 | Adenosine deaminase inhibitor | 0.082 0.009 DB00154 0.082 0.009 DBMET02087 0.054 0.027 DBMET02086 0.082 0.009 DB04557 | ||
| 0.098 | 0.026 | 0.098 | Epoxide hydrolase inhibitor | 0.098 0.026 DB00154 0.098 0.026 DB04557 | ||
| 0.109 | 0.037 | 0.109 | Phosphodiesterase 6D inhibitor | 0.109 0.037 DB00154 0.097 0.058 DBMET02087 0.109 0.037 DB04557 | ||
| 0.088 | 0.016 | 0.088 | Exportin-1 inhibitor | 0.088 0.016 DB00154 0.082 0.022 DBMET02087 0.088 0.016 DB04557 | ||
| 0.08 | 0.009 | 0.08 | Sphingosine 1-phosphate receptor agonist | 0.08 0.009 DB00154 0.066 0.013 DBMET02087 0.08 0.009 DB04557 | ||
| 0.092 | 0.021 | 0.092 | NMDA receptor glycine site agonist | 0.092 0.021 DB00154 0.092 0.021 DB04557 | ||
| 0.078 | 0.007 | 0.078 | Nicotinic acid receptor agonist | 0.078 0.007 DB00154 0.038 0.023 DBMET02087 0.078 0.007 DB04557 | ||
| 0.103 | 0.031 | 0.103 | Granulocyte macrophage colony stimulating factor agonist | 0.103 0.031 DB00154 0.103 0.031 DB04557 | ||
| 0.121 | 0.051 | 0.121 | Nav1.4 sodium channel blocker | 0.121 0.051 DB00154 0.121 0.051 DB04557 | ||
| 0.074 | 0.004 | 0.074 | Retinoid X receptor antagonist | 0.074 0.004 DB00154 0.053 0.01 DBMET02087 0.074 0.004 DB04557 | ||
| 0.072 | 0.001 | 0.33 | Thromboxane A2 agonist | 0.072 0.001 DB00154 0.086 0.001 DBMET02087 0.291 0 DBMET02086 0.072 0.001 DB04557 0.33 0 DB00917 | DB00917 | |
| 0.082 | 0.012 | 0.082 | Lipocortins synthesis agonist | 0.082 0.012 DB00154 0.069 0.023 DBMET02087 0.068 0.023 DBMET02086 0.082 0.012 DB04557 0.069 0.022 DB00917 | ||
| 0.091 | 0.021 | 0.091 | Carbonic anhydrase stimulant | 0.091 0.021 DB00154 0.091 0.021 DB04557 | ||
| 0.081 | 0.012 | 0.081 | CD45 antagonist | 0.081 0.012 DB00154 0.081 0.012 DB04557 | ||
| 0.081 | 0.012 | 0.081 | 5-Alpha-reductase inhibitor | 0.081 0.012 DB00154 0.081 0.012 DB04557 | ||
| 0.075 | 0.007 | 0.075 | Sphingosine 1-phosphate receptor 1 agonist | 0.075 0.007 DB00154 0.07 0.009 DBMET02087 0.075 0.007 DB04557 | ||
| 0.135 | 0.067 | 0.135 | Toll-Like receptor antagonist | 0.135 0.067 DB00154 0.135 0.067 DB04557 | ||
| 0.093 | 0.026 | 0.093 | Glucagon-like peptide 1 agonist | 0.093 0.026 DB00154 0.079 0.035 DBMET02087 0.093 0.026 DB04557 | ||
| 0.074 | 0.007 | 0.074 | Arginase inhibitor | 0.074 0.007 DB00154 0.05 0.015 DBMET02087 0.046 0.017 DBMET02086 0.074 0.007 DB04557 | ||
| 0.083 | 0.016 | 0.083 | MDM2 inhibitor | 0.083 0.016 DB00154 0.083 0.016 DB04557 | ||
| 0.068 | 0.002 | 0.068 | Carbonic anhydrase X inhibitor | 0.068 0.002 DB00154 0.038 0.003 DBMET02087 0.068 0.002 DB04557 | ||
| 0.068 | 0.002 | 0.068 | Carbonic anhydrase VIII inhibitor | 0.068 0.002 DB00154 0.038 0.003 DBMET02087 0.068 0.002 DB04557 | ||
| 0.208 | 0.142 | 0.262 | Hypoxia-inducible factor 1 alpha inhibitor | 0.208 0.142 DB00154 0.252 0.099 DBMET02086 0.208 0.142 DB04557 0.262 0.09 DB00917 | DB00917 | |
| 0.099 | 0.034 | 0.099 | mTOR complex 2 inhibitor | 0.099 0.034 DB00154 0.099 0.034 DB04557 | ||
| 0.071 | 0.008 | 0.071 | AMPA 4 receptor antagonist | 0.071 0.008 DB00154 0.071 0.008 DB04557 | ||
| 0.126 | 0.063 | 0.507 | Adenylate cyclase inhibitor | 0.126 0.063 DB00154 0.124 0.064 DBMET02087 0.507 0.005 DBMET02086 0.126 0.063 DB04557 0.356 0.009 DB00917 | DBMET02086 | |
| 0.085 | 0.023 | 0.085 | Cannabinoid CB1 receptor antagonist | 0.085 0.023 DB00154 0.079 0.028 DBMET02087 0.085 0.023 DB04557 | ||
| 0.289 | 0.228 | 0.289 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.289 0.228 DB00154 0.289 0.228 DB04557 | ||
| 0.064 | 0.003 | 0.064 | Prostaglandin H2 antagonist | 0.064 0.003 DB00154 0.042 0.005 DBMET02087 0.064 0.003 DB04557 0.033 0.01 DB00917 | ||
| 0.084 | 0.023 | 0.084 | Maillard reaction inhibitor | 0.084 0.023 DB00154 0.084 0.023 DB04557 | ||
| 0.118 | 0.058 | 0.118 | GABA receptor agonist | 0.118 0.058 DB00154 0.118 0.058 DB04557 | ||
| 0.13 | 0.071 | 0.13 | Cyclooxygenase 1 inhibitor | 0.13 0.071 DB00154 0.13 0.071 DB04557 | ||
| 0.141 | 0.082 | 0.276 | NOS3 expression enhancer | 0.141 0.082 DB00154 0.248 0.027 DBMET02086 0.141 0.082 DB04557 0.276 0.022 DB00917 | DB00917 | |
| 0.069 | 0.011 | 0.069 | Cholesterol esterase inhibitor | 0.069 0.011 DB00154 0.054 0.024 DBMET02087 0.069 0.011 DB04557 | ||
| 0.08 | 0.022 | 0.08 | GP IIb/IIIa receptor antagonist | 0.08 0.022 DB00154 0.08 0.022 DB04557 | ||
| 0.065 | 0.007 | 0.065 | Glutamate (mGluR3) antagonist | 0.065 0.007 DB00154 0.065 0.007 DB04557 | ||
| 0.062 | 0.004 | 0.062 | Retinoid X alpha receptor antagonist | 0.062 0.004 DB00154 0.044 0.011 DBMET02087 0.062 0.004 DB04557 | ||
| 0.062 | 0.004 | 0.062 | Free fatty acid receptor 1 agonist | 0.062 0.004 DB00154 0.018 0.012 DBMET02087 0.062 0.004 DB04557 | ||
| 0.103 | 0.046 | 0.162 | ABCA1 expression enhancer | 0.103 0.046 DB00154 0.123 0.029 DBMET02087 0.162 0.015 DBMET02086 0.103 0.046 DB04557 0.145 0.019 DB00917 | DBMET02086 | |
| 0.09 | 0.033 | 0.09 | Cannabinoid receptor antagonist | 0.09 0.033 DB00154 0.075 0.044 DBMET02087 0.09 0.033 DB04557 | ||
| 0.071 | 0.014 | 0.071 | HCV NS3/NS4A protease inhibitor | 0.071 0.014 DB00154 0.048 0.035 DBMET02087 0.071 0.014 DB04557 | ||
| 0.07 | 0.015 | 0.07 | Purinergic P2Y antagonist | 0.07 0.015 DB00154 0.07 0.015 DB04557 | ||
| 0.071 | 0.016 | 0.071 | Ryanodine receptor antagonist | 0.071 0.016 DB00154 0.071 0.016 DB04557 | ||
| 0.062 | 0.008 | 0.077 | Sphingosine kinase 1 inhibitor | 0.062 0.008 DB00154 0.077 0.005 DBMET02087 0.062 0.009 DBMET02086 0.062 0.008 DB04557 0.047 0.02 DB00917 | DBMET02087 | |
| 0.057 | 0.003 | 0.057 | Calcium-independent phospholipase A2 inhibitor | 0.057 0.003 DB00154 0.057 0.003 DBMET02087 0.041 0.009 DBMET02086 0.057 0.003 DB04557 0.038 0.014 DB00917 | ||
| 0.058 | 0.004 | 0.133 | Leukotriene B4 receptor 2 antagonist | 0.058 0.004 DB00154 0.133 0.003 DBMET02087 0.071 0.004 DBMET02086 0.058 0.004 DB04557 0.058 0.004 DB00917 | DBMET02087 | |
| 0.058 | 0.005 | 0.099 | HMG CoA reductase inhibitor | 0.058 0.005 DB00154 0.099 0.002 DBMET02087 0.094 0.002 DBMET02086 0.058 0.005 DB04557 0.091 0.003 DB00917 | DBMET02087 | |
| 0.064 | 0.011 | 0.064 | Factor XIIIa inhibitor | 0.064 0.011 DB00154 0.064 0.011 DB04557 | ||
| 0.062 | 0.009 | 0.062 | GABA uptake inhibitor | 0.062 0.009 DB00154 0.062 0.009 DB04557 | ||
| 0.075 | 0.023 | 0.075 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.075 0.023 DB00154 0.062 0.033 DBMET02087 0.075 0.023 DB04557 | ||
| 0.068 | 0.015 | 0.068 | Squalene epoxidase inhibitor | 0.068 0.015 DB00154 0.068 0.015 DB04557 | ||
| 0.057 | 0.005 | 0.07 | Vanilloid 3 antagonist | 0.057 0.005 DB00154 0.07 0.004 DBMET02087 0.057 0.005 DB04557 | DBMET02087 | |
| 0.095 | 0.043 | 0.095 | Topoisomerase II alpha inhibitor | 0.095 0.043 DB00154 0.095 0.043 DB04557 | ||
| 0.14 | 0.089 | 0.14 | Anticoagulant | 0.14 0.089 DB00154 0.14 0.089 DB04557 | ||
| 0.112 | 0.061 | 0.112 | Acetylcholine release stimulant | 0.112 0.061 DB00154 0.112 0.061 DB04557 | ||
| 0.057 | 0.006 | 0.057 | Glutamate (mGluR8) antagonist | 0.057 0.006 DB00154 0.038 0.019 DBMET02087 0.039 0.018 DBMET02086 0.057 0.006 DB04557 | ||
| 0.062 | 0.013 | 0.062 | AICAR transformylase inhibitor | 0.062 0.013 DB00154 0.062 0.013 DB04557 | ||
| 0.201 | 0.153 | 0.201 | Thyroid hormone beta antagonist | 0.201 0.153 DB00154 0.201 0.153 DB04557 | ||
| 0.061 | 0.013 | 0.061 | Glutamate (mGluR4) antagonist | 0.061 0.013 DB00154 0.061 0.013 DB04557 | ||
| 0.065 | 0.016 | 0.065 | Heparanase inhibitor | 0.065 0.016 DB00154 0.065 0.016 DB04557 | ||
| 0.052 | 0.004 | 0.052 | Glutamate (mGluR3) agonist | 0.052 0.004 DB00154 0.031 0.025 DBMET02087 0.052 0.004 DB04557 | ||
| 0.054 | 0.007 | 0.054 | Lysine carboxypeptidase inhibitor | 0.054 0.007 DB00154 0.041 0.01 DBMET02087 0.054 0.007 DB04557 | ||
| 0.051 | 0.004 | 0.051 | Elastase 3B inhibitor | 0.051 0.004 DB00154 0.037 0.011 DBMET02087 0.051 0.004 DB04557 | ||
| 0.051 | 0.004 | 0.051 | Elastase 3A inhibitor | 0.051 0.004 DB00154 0.037 0.011 DBMET02087 0.051 0.004 DB04557 | ||
| 0.051 | 0.004 | 0.051 | Elastase 2B inhibitor | 0.051 0.004 DB00154 0.037 0.011 DBMET02087 0.051 0.004 DB04557 | ||
| 0.062 | 0.016 | 0.062 | Thymidylate synthase inhibitor | 0.062 0.016 DB00154 0.062 0.016 DB04557 | ||
| 0.048 | 0.003 | 0.048 | Retinoid X beta receptor antagonist | 0.048 0.003 DB00154 0.028 0.005 DBMET02087 0.048 0.003 DB04557 | ||
| 0.094 | 0.049 | 0.192 | Antineoplastic antibiotic | 0.094 0.049 DB00154 0.192 0.023 DBMET02087 0.147 0.031 DBMET02086 0.094 0.049 DB04557 0.167 0.027 DB00917 | DBMET02087 | |
| 0.054 | 0.009 | 0.054 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.054 0.009 DB00154 0.041 0.02 DBMET02087 0.054 0.009 DB04557 | ||
| 0.047 | 0.003 | 0.047 | Calcium-dependent phospholipase A2 inhibitor | 0.047 0.003 DB00154 0.03 0.004 DBMET02087 0.047 0.003 DB04557 | ||
| 0.052 | 0.008 | 0.052 | Free fatty acid receptor 1 antagonist | 0.052 0.008 DB00154 0.052 0.008 DB04557 | ||
| 0.067 | 0.024 | 0.067 | Glucosylceramidase inhibitor | 0.067 0.024 DB00154 0.056 0.037 DBMET02087 0.067 0.024 DB04557 | ||
| 0.049 | 0.007 | 0.049 | Purinergic P2Y12 antagonist | 0.049 0.007 DB00154 0.022 0.017 DBMET02087 0.049 0.007 DB04557 | ||
| 0.13 | 0.088 | 0.13 | Cyclooxygenase inhibitor | 0.13 0.088 DB00154 0.13 0.088 DB04557 | ||
| 0.058 | 0.016 | 0.058 | Leukotriene A4 hydrolase inhibitor | 0.058 0.016 DB00154 0.058 0.016 DB04557 | ||
| 0.05 | 0.008 | 0.05 | Integrin alpha1beta1 antagonist | 0.05 0.008 DB00154 0.05 0.008 DB04557 | ||
| 0.079 | 0.038 | 0.079 | Potassium channel (Tandem pore domain) blocker | 0.079 0.038 DB00154 0.079 0.038 DB04557 | ||
| 0.113 | 0.072 | 0.113 | Proteasome inhibitor | 0.113 0.072 DB00154 0.113 0.072 DB04557 | ||
| 0.063 | 0.023 | 0.063 | Adenine nucleotide translocase inhibitor | 0.063 0.023 DB00154 0.061 0.027 DBMET02087 0.063 0.023 DB04557 | ||
| 0.073 | 0.033 | 0.073 | Protease 3C (Human rhinovirus) inhibitor | 0.073 0.033 DB00154 0.073 0.033 DB04557 | ||
| 0.055 | 0.015 | 0.055 | G protein-coupled receptor agonist | 0.055 0.015 DB00154 0.052 0.017 DBMET02087 0.055 0.015 DB04557 | ||
| 0.063 | 0.024 | 0.063 | Nicotinic alpha3beta2 receptor antagonist | 0.063 0.024 DB00154 0.063 0.024 DB04557 | ||
| 0.053 | 0.014 | 0.053 | Cholecystokinin B agonist | 0.053 0.014 DB00154 0.053 0.014 DB04557 | ||
| 0.043 | 0.005 | 0.043 | Glutamate (mGluR1a) agonist | 0.043 0.005 DB00154 0.043 0.005 DB04557 | ||
| 0.067 | 0.029 | 0.067 | Carbonic anhydrase VB inhibitor | 0.067 0.029 DB00154 0.067 0.029 DB04557 | ||
| 0.042 | 0.004 | 0.042 | Vanilloid 2 agonist | 0.042 0.004 DB00154 0.026 0.015 DBMET02087 0.026 0.016 DBMET02086 0.042 0.004 DB04557 | ||
| 0.055 | 0.017 | 0.055 | Guanylate cyclase inhibitor | 0.055 0.017 DB00154 0.055 0.017 DB04557 | ||
| 0.087 | 0.05 | 0.087 | D-Ala-D-Ala ligase inhibitor | 0.087 0.05 DB00154 0.087 0.05 DB04557 | ||
| 0.048 | 0.011 | 0.048 | Peptide deformylase inhibitor | 0.048 0.011 DB00154 0.048 0.011 DB04557 | ||
| 0.112 | 0.075 | 0.112 | Beta amyloid protein antagonist | 0.112 0.075 DB00154 0.112 0.075 DB04557 | ||
| 0.054 | 0.017 | 0.054 | Glutamate (mGluR group III) antagonist | 0.054 0.017 DB00154 0.054 0.017 DB04557 | ||
| 0.051 | 0.014 | 0.051 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.051 0.014 DB00154 0.051 0.014 DB04557 | ||
| 0.048 | 0.011 | 0.048 | VCAM-1 antagonist | 0.048 0.011 DB00154 0.048 0.011 DB04557 | ||
| 0.047 | 0.011 | 0.047 | VCAM antagonist | 0.047 0.011 DB00154 0.047 0.011 DB04557 | ||
| 0.041 | 0.005 | 0.041 | Glutamate (mGluR1) agonist | 0.041 0.005 DB00154 0.041 0.005 DB04557 | ||
| 0.039 | 0.003 | 0.055 | Vitamin D receptor agonist | 0.039 0.003 DB00154 0.052 0.002 DBMET02087 0.055 0.002 DBMET02086 0.039 0.003 DB04557 0.046 0.003 DB00917 | DBMET02086 | |
| 0.051 | 0.016 | 0.051 | Angiotensin AT1 receptor antagonist | 0.051 0.016 DB00154 0.051 0.016 DB04557 | ||
| 0.175 | 0.14 | 0.175 | Nitric-oxide synthase stimulant | 0.175 0.14 DB00154 0.175 0.14 DB04557 | ||
| 0.085 | 0.05 | 0.085 | Thioredoxin reductase inhibitor | 0.085 0.05 DB00154 0.085 0.05 DB04557 | ||
| 0.059 | 0.025 | 0.059 | Integrin antagonist | 0.059 0.025 DB00154 0.059 0.025 DB04557 | ||
| 0.049 | 0.015 | 0.049 | Farnesoid X receptor agonist | 0.049 0.015 DB00154 0.049 0.015 DB04557 | ||
| 0.04 | 0.007 | 0.04 | Retinoid X gamma receptor agonist | 0.04 0.007 DB00154 0.029 0.011 DBMET02087 0.04 0.007 DB04557 0.021 0.019 DB00917 | ||
| 0.041 | 0.008 | 0.656 | Prostaglandin EP1 antagonist | 0.041 0.008 DB00154 0.068 0.005 DBMET02087 0.621 0.002 DBMET02086 0.041 0.008 DB04557 0.656 0.002 DB00917 | DB00917 | |
| 0.042 | 0.009 | 0.042 | Kynurenine 3 monooxygenase inhibitor | 0.042 0.009 DB00154 0.042 0.009 DB04557 | ||
| 0.074 | 0.042 | 0.074 | Carbonic anhydrase VA inhibitor | 0.074 0.042 DB00154 0.074 0.042 DB04557 | ||
| 0.054 | 0.021 | 0.054 | Leukocyte elastase inhibitor | 0.054 0.021 DB00154 0.054 0.021 DB04557 | ||
| 0.088 | 0.056 | 0.088 | Antineoplastic alkaloid | 0.088 0.056 DB00154 0.088 0.056 DB04557 | ||
| 0.037 | 0.006 | 0.037 | Retinoid X gamma receptor antagonist | 0.037 0.006 DB00154 0.035 0.007 DBMET02087 0.037 0.006 DB04557 0.028 0.017 DB00917 | ||
| 0.05 | 0.019 | 0.05 | GABA B receptor antagonist | 0.05 0.019 DB00154 0.05 0.019 DB04557 | ||
| 0.067 | 0.037 | 0.067 | NMDA 2C receptor antagonist | 0.067 0.037 DB00154 0.067 0.037 DB04557 | ||
| 0.042 | 0.012 | 0.042 | AMPA 3 receptor antagonist | 0.042 0.012 DB00154 0.042 0.012 DB04557 | ||
| 0.036 | 0.007 | 0.036 | Nicotinic acid receptor 2 antagonist | 0.036 0.007 DB00154 0.036 0.007 DB04557 | ||
| 0.047 | 0.018 | 0.047 | Sphingosine 1-phosphate receptor 3 agonist | 0.047 0.018 DB00154 0.045 0.018 DBMET02087 0.047 0.018 DB04557 | ||
| 0.042 | 0.013 | 0.042 | Glucagon receptor antagonist | 0.042 0.013 DB00154 0.042 0.013 DB04557 | ||
| 0.084 | 0.055 | 0.084 | Inducible nitric-oxide synthase inhibitor | 0.084 0.055 DB00154 0.084 0.055 DB04557 | ||
| 0.067 | 0.039 | 0.067 | Beta 3 adrenoreceptor antagonist | 0.067 0.039 DB00154 0.067 0.039 DB04557 | ||
| 0.059 | 0.031 | 0.059 | Angiotensin-converting enzyme inhibitor | 0.059 0.031 DB00154 0.056 0.035 DBMET02087 0.059 0.031 DB04557 | ||
| 0.04 | 0.012 | 0.04 | Carboxypeptidase B inhibitor | 0.04 0.012 DB00154 0.032 0.025 DBMET02087 0.04 0.012 DB04557 | ||
| 0.036 | 0.008 | 0.036 | 5-Alpha-reductase 2 inhibitor | 0.036 0.008 DB00154 0.036 0.008 DB04557 | ||
| 0.04 | 0.012 | 0.04 | Uridine phosphorylase inhibitor | 0.04 0.012 DB00154 0.04 0.012 DB04557 | ||
| 0.044 | 0.017 | 0.044 | Phosphoglycerate kinase inhibitor | 0.044 0.017 DB00154 0.036 0.023 DBMET02087 0.044 0.017 DB04557 | ||
| 0.056 | 0.029 | 0.056 | Prolyl endopeptidase inhibitor | 0.056 0.029 DB00154 0.056 0.029 DB04557 | ||
| 0.041 | 0.014 | 0.041 | Peroxisome proliferator-activated receptor delta antagonist | 0.041 0.014 DB00154 0.041 0.014 DB04557 | ||
| 0.056 | 0.029 | 0.056 | Diacylglycerol O-acyltransferase inhibitor | 0.056 0.029 DB00154 0.056 0.029 DB04557 | ||
| 0.052 | 0.025 | 0.058 | Microtubule stabilization | 0.052 0.025 DB00154 0.058 0.016 DBMET02087 0.051 0.027 DBMET02086 0.052 0.025 DB04557 0.053 0.024 DB00917 | DBMET02087 | |
| 0.03 | 0.005 | 0.03 | Isoleucine-tRNA ligase inhibitor | 0.03 0.005 DB00154 0.028 0.007 DBMET02087 0.022 0.018 DBMET02086 0.03 0.005 DB04557 | ||
| 0.051 | 0.026 | 0.051 | Cytokine production stimulant | 0.051 0.026 DB00154 0.051 0.026 DB04557 | ||
| 0.086 | 0.061 | 0.15 | Interleukin 5 antagonist | 0.086 0.061 DB00154 0.15 0.011 DBMET02086 0.086 0.061 DB04557 0.144 0.013 DB00917 | DBMET02086 | |
| 0.038 | 0.013 | 0.038 | Epoxide hydrolase 1 inhibitor | 0.038 0.013 DB00154 0.038 0.013 DB04557 | ||
| 0.032 | 0.008 | 0.032 | Retinoid X beta receptor agonist | 0.032 0.008 DB00154 0.022 0.014 DBMET02087 0.032 0.008 DB04557 | ||
| 0.029 | 0.005 | 0.029 | Ileal bile acid transport inhibitor | 0.029 0.005 DB00154 0.029 0.005 DB04557 | ||
| 0.078 | 0.054 | 0.078 | Metalloproteinase-2 inhibitor | 0.078 0.054 DB00154 0.078 0.054 DB04557 | ||
| 0.029 | 0.005 | 0.029 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.029 0.005 DB00154 0.017 0.009 DBMET02087 0.029 0.005 DB04557 | ||
| 0.049 | 0.025 | 0.049 | Macrophage elastase inhibitor | 0.049 0.025 DB00154 0.049 0.025 DB04557 | ||
| 0.042 | 0.019 | 0.042 | Calcitonin receptor agonist | 0.042 0.019 DB00154 0.035 0.023 DBMET02087 0.042 0.019 DB04557 | ||
| 0.045 | 0.021 | 0.045 | Dihydropteroate synthase inhibitor | 0.045 0.021 DB00154 0.045 0.021 DB04557 | ||
| 0.033 | 0.01 | 0.033 | Thyroid hormone agonist | 0.033 0.01 DB00154 0.033 0.01 DB04557 | ||
| 0.028 | 0.005 | 0.028 | Neuraminidase (Influenza B) inhibitor | 0.028 0.005 DB00154 0.026 0.007 DBMET02087 0.025 0.008 DBMET02086 0.028 0.005 DB04557 0.022 0.013 DB00917 | ||
| 0.039 | 0.016 | 0.039 | Angiotensin II receptor antagonist | 0.039 0.016 DB00154 0.039 0.016 DB04557 | ||
| 0.077 | 0.054 | 0.077 | Estrogen receptor alpha antagonist | 0.077 0.054 DB00154 0.077 0.054 DB04557 | ||
| 0.049 | 0.026 | 0.049 | NMDA receptor subunit 3B antagonist | 0.049 0.026 DB00154 0.049 0.026 DB04557 | ||
| 0.066 | 0.044 | 0.066 | Cannabinoid receptor agonist | 0.066 0.044 DB00154 0.066 0.044 DB04557 | ||
| 0.053 | 0.03 | 0.053 | Bombesin 2 receptor antagonist | 0.053 0.03 DB00154 0.051 0.033 DBMET02087 0.053 0.03 DB04557 | ||
| 0.043 | 0.021 | 0.043 | Glucagon-like peptide 1 receptor antagonist | 0.043 0.021 DB00154 0.043 0.021 DB04557 | ||
| 0.067 | 0.045 | 0.067 | Carbonic anhydrase V inhibitor | 0.067 0.045 DB00154 0.067 0.045 DB04557 | ||
| 0.048 | 0.027 | 0.051 | Neuraminidase (Influenza A) inhibitor | 0.048 0.027 DB00154 0.051 0.023 DBMET02087 0.05 0.024 DBMET02086 0.048 0.027 DB04557 0.043 0.037 DB00917 | DBMET02087 | |
| 0.029 | 0.009 | 0.029 | 5-Alpha-reductase 1 inhibitor | 0.029 0.009 DB00154 0.029 0.009 DB04557 | ||
| 0.024 | 0.004 | 0.024 | Glutamate (mGluR6) agonist | 0.024 0.004 DB00154 0.024 0.004 DB04557 | ||
| 0.17 | 0.151 | 0.17 | Cardiotonic | 0.17 0.151 DB00154 0.17 0.151 DB04557 | ||
| 0.055 | 0.035 | 0.055 | Aldose reductase inhibitor | 0.055 0.035 DB00154 0.055 0.035 DB04557 | ||
| 0.023 | 0.004 | 0.023 | Carbonic anhydrase XI inhibitor | 0.023 0.004 DB00154 0.023 0.004 DB04557 | ||
| 0.039 | 0.019 | 0.039 | Ceramide glucosyltransferase inhibitor | 0.039 0.019 DB00154 0.039 0.019 DB04557 | ||
| 0.075 | 0.056 | 0.075 | Nicotinic alpha4beta2 receptor antagonist | 0.075 0.056 DB00154 0.075 0.056 DB04557 | ||
| 0.051 | 0.032 | 0.051 | Carbonic anhydrase XIV inhibitor | 0.051 0.032 DB00154 0.051 0.032 DB04557 | ||
| 0.031 | 0.012 | 0.031 | Hedgehog signaling activator | 0.031 0.012 DB00154 0.031 0.012 DB04557 | ||
| 0.043 | 0.024 | 0.043 | Dopamine D5 agonist | 0.043 0.024 DB00154 0.043 0.024 DB04557 | ||
| 0.03 | 0.011 | 0.035 | Toll-Like receptor 4 agonist | 0.03 0.011 DB00154 0.035 0.007 DBMET02087 0.028 0.014 DBMET02086 0.03 0.011 DB04557 0.026 0.019 DB00917 | DBMET02087 | |
| 0.042 | 0.024 | 0.042 | NMDA receptor subunit 3A antagonist | 0.042 0.024 DB00154 0.042 0.024 DB04557 | ||
| 0.023 | 0.005 | 0.023 | Methylmalonyl-CoA mutase inhibitor | 0.023 0.005 DB00154 0.021 0.006 DBMET02087 0.023 0.005 DB04557 | ||
| 0.096 | 0.078 | 0.096 | Factor V inhibitor | 0.096 0.078 DB00154 0.096 0.078 DB04557 | ||
| 0.092 | 0.074 | 0.092 | Nitric-oxide synthase inhibitor | 0.092 0.074 DB00154 0.092 0.074 DB04557 | ||
| 0.137 | 0.119 | 0.137 | Amyloid beta aggregation inhibitor | 0.137 0.119 DB00154 0.137 0.119 DB04557 | ||
| 0.045 | 0.027 | 0.045 | Oxytocin agonist | 0.045 0.027 DB00154 0.045 0.027 DB04557 | ||
| 0.08 | 0.062 | 0.08 | Caspase 7 inhibitor | 0.08 0.062 DB00154 0.08 0.062 DB04557 | ||
| 0.025 | 0.008 | 0.025 | Aminopeptidase A inhibitor | 0.025 0.008 DB00154 0.017 0.013 DBMET02087 0.025 0.008 DB04557 | ||
| 0.074 | 0.057 | 0.241 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.074 0.057 DB00154 0.241 0.006 DBMET02086 0.074 0.057 DB04557 0.154 0.018 DB00917 | DBMET02086 | |
| 0.035 | 0.018 | 0.04 | Methionyl aminopeptidase 1 inhibitor | 0.035 0.018 DB00154 0.04 0.012 DBMET02087 0.035 0.018 DB04557 | DBMET02087 | |
| 0.031 | 0.014 | 0.036 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.014 DB00154 0.036 0.005 DBMET02087 0.031 0.014 DB04557 | DBMET02087 | |
| 0.094 | 0.077 | 0.094 | Falcipain 3 inhibitor | 0.094 0.077 DB00154 0.094 0.077 DB04557 | ||
| 0.068 | 0.051 | 0.068 | Prostaglandin-E synthase inhibitor | 0.068 0.051 DB00154 0.068 0.051 DB04557 | ||
| 0.06 | 0.044 | 0.06 | TRPA1 antagonist | 0.06 0.044 DB00154 0.06 0.044 DB04557 | ||
| 0.041 | 0.025 | 0.042 | Retinoic acid alpha receptor agonist | 0.041 0.025 DB00154 0.042 0.022 DBMET02087 0.041 0.025 DB04557 | DBMET02087 | |
| 0.035 | 0.019 | 0.035 | Caspase 2 inhibitor | 0.035 0.019 DB00154 0.035 0.019 DB04557 | ||
| 0.036 | 0.02 | 0.036 | Carnitine palmitoyltransferase inhibitor | 0.036 0.02 DB00154 0.036 0.02 DB04557 | ||
| 0.022 | 0.007 | 0.022 | Thyroid hormone alpha antagonist | 0.022 0.007 DB00154 0.022 0.007 DB04557 | ||
| 0.024 | 0.008 | 0.024 | Caspase 8 inhibitor | 0.024 0.008 DB00154 0.024 0.008 DB04557 | ||
| 0.039 | 0.023 | 0.039 | Inosine monophosphate dehydrogenase inhibitor | 0.039 0.023 DB00154 0.039 0.023 DB04557 | ||
| 0.041 | 0.025 | 0.041 | Urate transporter 1 inhibitor | 0.041 0.025 DB00154 0.041 0.025 DB04557 | ||
| 0.031 | 0.015 | 0.031 | Purinergic P2Y15 antagonist | 0.031 0.015 DB00154 0.031 0.015 DB04557 | ||
| 0.048 | 0.035 | 0.048 | Metalloproteinase-3 inhibitor | 0.048 0.035 DB00154 0.048 0.035 DB04557 | ||
| 0.035 | 0.022 | 0.035 | Carnitine palmitoyltransferase 1 inhibitor | 0.035 0.022 DB00154 0.035 0.022 DB04557 | ||
| 0.024 | 0.012 | 0.024 | Integrin alphaVbeta3 antagonist | 0.024 0.012 DB00154 0.024 0.012 DB04557 | ||
| 0.053 | 0.041 | 0.053 | Matrix metalloproteinase (membrane-type) inhibitor | 0.053 0.041 DB00154 0.053 0.041 DB04557 | ||
| 0.022 | 0.01 | 0.022 | Toll-Like receptor 8 agonist | 0.022 0.01 DB00154 0.022 0.01 DB04557 | ||
| 0.024 | 0.013 | 0.024 | Elastase 2A inhibitor | 0.024 0.013 DB00154 0.024 0.013 DB04557 | ||
| 0.024 | 0.013 | 0.024 | Elastase 2 inhibitor | 0.024 0.013 DB00154 0.024 0.013 DB04557 | ||
| 0.016 | 0.004 | 0.025 | Calcineurin inhibitor | 0.016 0.004 DB00154 0.014 0.005 DBMET02087 0.021 0.003 DBMET02086 0.016 0.004 DB04557 0.025 0.003 DB00917 | DB00917 | |
| 0.091 | 0.08 | 0.091 | Glutamate (mGluR7) agonist | 0.091 0.08 DB00154 0.091 0.08 DB04557 | ||
| 0.037 | 0.026 | 0.037 | Histone deacetylase 7 inhibitor | 0.037 0.026 DB00154 0.037 0.026 DB04557 | ||
| 0.113 | 0.102 | 0.142 | Papain-like protease (SARS coronavirus) inhibitor | 0.113 0.102 DB00154 0.142 0.042 DBMET02087 0.131 0.058 DBMET02086 0.113 0.102 DB04557 0.131 0.058 DB00917 | DBMET02087 | |
| 0.061 | 0.05 | 0.086 | Neuraminidase (influenza) inhibitor | 0.061 0.05 DB00154 0.068 0.038 DBMET02087 0.086 0.022 DBMET02086 0.061 0.05 DB04557 0.078 0.027 DB00917 | DBMET02086 | |
| 0.058 | 0.046 | 0.092 | Neuraminidase inhibitor | 0.058 0.046 DB00154 0.078 0.027 DBMET02087 0.092 0.019 DBMET02086 0.058 0.046 DB04557 0.082 0.024 DB00917 | DBMET02086 | |
| 0.04 | 0.029 | 0.04 | Thymidine kinase inhibitor | 0.04 0.029 DB00154 0.04 0.029 DB04557 | ||
| 0.07 | 0.059 | 0.07 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.07 0.059 DB00154 0.07 0.059 DB04557 | ||
| 0.019 | 0.009 | 0.019 | Telomerase stimulant | 0.019 0.009 DB00154 0.019 0.009 DB04557 | ||
| 0.021 | 0.011 | 0.021 | Retinoic acid beta receptor agonist | 0.021 0.011 DB00154 0.02 0.013 DBMET02087 0.021 0.011 DB04557 | ||
| 0.024 | 0.015 | 0.027 | Retinoic acid receptor agonist | 0.024 0.015 DB00154 0.027 0.012 DBMET02087 0.024 0.015 DB04557 | DBMET02087 | |
| 0.053 | 0.043 | 0.053 | Dihydroorotate oxidase inhibitor | 0.053 0.043 DB00154 0.053 0.043 DB04557 | ||
| 0.014 | 0.005 | 0.014 | Immunosuppressant Cyclosporine-like | 0.014 0.005 DB00154 0.011 0.008 DBMET02087 0.014 0.005 DB04557 | ||
| 0.048 | 0.039 | 0.048 | Potassium channel (Inward rectifier) activator | 0.048 0.039 DB00154 0.048 0.039 DB04557 | ||
| 0.129 | 0.12 | 0.129 | CF transmembrane conductance regulator agonist | 0.129 0.12 DB00154 0.129 0.12 DB04557 | ||
| 0.028 | 0.019 | 0.028 | LFA antagonist | 0.028 0.019 DB00154 0.028 0.019 DB04557 | ||
| 0.042 | 0.034 | 0.042 | Dihydrofolate reductase inhibitor | 0.042 0.034 DB00154 0.042 0.034 DB04557 | ||
| 0.023 | 0.014 | 0.025 | Retinoic acid gamma receptor agonist | 0.023 0.014 DB00154 0.025 0.01 DBMET02087 0.023 0.014 DB04557 | DBMET02087 | |
| 0.046 | 0.038 | 0.046 | Potassium channel (ATP-sensitive) activator | 0.046 0.038 DB00154 0.046 0.038 DB04557 | ||
| 0.027 | 0.019 | 0.027 | Urotensin II agonist | 0.027 0.019 DB00154 0.027 0.019 DB04557 | ||
| 0.023 | 0.015 | 0.023 | ICAM 1 antagonist | 0.023 0.015 DB00154 0.023 0.015 DB04557 | ||
| 0.028 | 0.021 | 0.028 | Liver X receptor beta antagonist | 0.028 0.021 DB00154 0.028 0.021 DB04557 | ||
| 0.022 | 0.015 | 0.022 | Purinergic P2T antagonist | 0.022 0.015 DB00154 0.022 0.015 DB04557 | ||
| 0.015 | 0.008 | 0.015 | Integrin beta6 antagonist | 0.015 0.008 DB00154 0.015 0.008 DB04557 | ||
| 0.024 | 0.018 | 0.024 | Kainate receptor 4 antagonist | 0.024 0.018 DB00154 0.024 0.018 DB04557 | ||
| 0.022 | 0.015 | 0.022 | Geranylgeranyltransferase inhibitor | 0.022 0.015 DB00154 0.022 0.015 DB04557 | ||
| 0.027 | 0.02 | 0.027 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.027 0.02 DB00154 0.027 0.02 DB04557 | ||
| 0.041 | 0.037 | 0.041 | Fructose-1,6-bisphosphatase inhibitor | 0.041 0.037 DB00154 0.041 0.037 DB04557 | ||
| 0.013 | 0.009 | 0.013 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.013 0.009 DB00154 0.013 0.009 DB04557 | ||
| 0.026 | 0.023 | 0.026 | AMPA 1 receptor antagonist | 0.026 0.023 DB00154 0.026 0.023 DB04557 | ||
| 0.013 | 0.01 | 0.013 | Angiotensin AT1B receptor antagonist | 0.013 0.01 DB00154 0.013 0.01 DB04557 | ||
| 0.007 | 0.005 | 0.007 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.007 0.005 DB00154 0.007 0.005 DB04557 | ||
| 0.057 | 0.055 | 0.057 | Neutrophil collagenase inhibitor | 0.057 0.055 DB00154 0.057 0.055 DB04557 | ||
| 0.021 | 0.018 | 0.027 | Vitamin D receptor antagonist | 0.021 0.018 DB00154 0.023 0.013 DBMET02087 0.027 0.009 DBMET02086 0.021 0.018 DB04557 0.024 0.012 DB00917 | DBMET02086 | |
| 0.05 | 0.048 | 0.05 | DNA helicase inhibitor | 0.05 0.048 DB00154 0.05 0.048 DB04557 | ||
| 0.055 | 0.053 | 0.056 | HIV-1 integrase (3'-Processing) inhibitor | 0.055 0.053 DB00154 0.056 0.052 DBMET02087 0.055 0.053 DB04557 | DBMET02087 | |
| 0.015 | 0.012 | 0.015 | Purinergic P2Y1 agonist | 0.015 0.012 DB00154 0.015 0.012 DB04557 | ||
| 0.053 | 0.051 | 0.053 | Androgen agonist | 0.053 0.051 DB00154 0.053 0.051 DB04557 | ||
| 0.088 | 0.086 | 0.088 | Carbonic anhydrase XV inhibitor | 0.088 0.086 DB00154 0.088 0.086 DB04557 | ||
| 0.073 | 0.071 | 0.073 | ErbB-3 antagonist | 0.073 0.071 DB00154 0.073 0.071 DB04557 | ||
| 0.006 | 0.005 | 0.006 | Integrin alpha5beta6 antagonist | 0.006 0.005 DB00154 0.006 0.005 DB04557 | ||
| 0.051 | 0.049 | 0.051 | HIV-1 integrase (Strand Transfer) inhibitor | 0.051 0.049 DB00154 0.051 0.049 DBMET02087 0.051 0.049 DB04557 | ||
| 0.036 | 0.035 | 0.036 | Histone deacetylase 9 inhibitor | 0.036 0.035 DB00154 0.036 0.035 DB04557 | ||
| 0.028 | 0.028 | 0.03 | Cholesterol ester transfer protein antagonist | 0.03 0.024 DBMET02087 | DBMET02087 | |
| 0.081 | 0.084 | 0.097 | Protease inhibitor | 0.097 0.068 DBMET02087 | DBMET02087 | |
| 0.014 | 0.02 | 0.017 | Retinoic acid receptor antagonist | 0.017 0.015 DBMET02087 | DBMET02087 | |
| 0.052 | 0.064 | 0.078 | Transcription factor AP-1 inhibitor | 0.078 0.023 DBMET02087 | DBMET02087 | |
| 0.04 | 0.053 | 0.094 | Protein 50S ribosomal subunit inhibitor | 0.06 0.031 DBMET02087 0.094 0.015 DBMET02086 0.091 0.015 DB00917 | DBMET02086 | |
| 0.051 | 0.087 | 0.065 | Histone deacetylase SIRT1 stimulant | 0.065 0.062 DBMET02087 | DBMET02087 | |
| 0.051 | 0.087 | 0.065 | Histone deacetylase stimulant | 0.065 0.062 DBMET02087 | DBMET02087 | |
| 0.011 | 0.059 | 0.028 | RNA-directed RNA polymerase stimulant | 0.028 0.022 DBMET02086 | DBMET02086 | |
| 0.015 | 0.069 | 0.032 | Plasmepsin I inhibitor | 0.032 0.019 DBMET02087 | DBMET02087 | |
| 0.059 | 0.121 | 0.384 | Bronchodilator | 0.371 0.006 DBMET02086 0.384 0.006 DB00917 | DB00917 | |
| 0.069 | 0.133 | 0.162 | T cell inhibitor | 0.162 0.009 DBMET02086 0.16 0.009 DB00917 | DBMET02086 | |
| 0.086 | 0.16 | 0.11 | Interleukin 1 antagonist | 0.11 0.105 DBMET02087 | DBMET02087 | |
| 0.08 | 0.191 | 0.123 | Interleukin 2 antagonist | 0.123 0.041 DB00917 | DB00917 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |